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Abstract 
 
TRPV1 Channels Contribute to Behavioral Hypersensitivity and 
Spontaneous Activity in Nociceptors After Spinal Cord Injury 
 
Publication No.___________ 
Zizhen Wu, M.S. 
Supervisory Professors: Edgar T. Walters, Ph.D. 
  
 
 
A majority of persons who have sustained spinal cord injury (SCI) develop 
chronic pain. While most investigators have assumed that the critical mechanisms 
underlying neuropathic pain after SCI are restricted to the central nervous system 
(CNS), recent studies showed that contusive SCI results in a large increase in 
spontaneous activity in primary nociceptors, which is correlated significantly with 
mechanical allodynia and thermal hyperalgesia. Upregulation of ion channel 
transient receptor vanilloid 1 (TRPV1) has been observed in the dorsal horn of the 
spinal cord after SCI, and reduction of SCI-induced hyperalgesia by a TRPV1 
antagonist has been claimed. However, the possibility that SCI enhances TRPV1 
expression and function in nociceptors has not been tested. I produced contusive 
SCI at thoracic level T10 in adult, male rats and harvested lumbar (L4/L5) dorsal 
root ganglia (DRG) from sham-treated and SCI rats 3 days and 1 month after 
injury, as well as from age-matched naive control rats. Whole-cell patch clamp 
recordings were made from small (soma diameter <30 µm) DRG neurons 18 hours 
after dissociation. Capsaicin-induced currents were significantly increased 1 
month, but not 3 days, after SCI compared to neurons from control animals. In 
addition, Ca2+ transients imaged during capsaicin application were significantly 
	   v	  
greater 1 month after SCI. Western blot experiments indicated that expression of 
TRPV1 protein in DRG is also increased 1 month after SCI. A major role for 
TRPV1 channels in pain-related behavior was indicated by the ability of a specific 
TRPV1 antagonist, AMG9810, to reverse SCI-induced hypersensitivity of hindlimb 
withdrawal responses to heat and mechanical stimuli. Similar reversal of 
behavioral hypersensitivity was induced by intrathecal delivery of 
oligodeoxynucleotides antisense to TRPV1, which knocked down TRPV1 protein 
and reduced capsaicin-evoked currents. TRPV1 knockdown also decreased the 
incidence of spontaneous activity in dissociated nociceptors after SCI. Limited 
activation of TRPV1 was found to induce prolonged repetitive firing without 
accommodation or desensitization, and this effect was enhanced by SCI. These 
data suggest that SCI enhances TRPV1 expression and function in primary 
nociceptors, increasing the excitability and spontaneous activity of these neurons, 
thus contributing to chronic pain after SCI. 
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CHAPTER 1: Introduction 
 
1.1. Spinal cord injury (SCI) induces chronic pain 
The spinal cord includes neurons and major bundles of axons that carry 
impulses to and from the brain and the rest of the body. Although the spinal cord is 
surrounded and protected by rings of bone (vertebrae), it can be damaged, most 
commonly by vehicle accidents, war injuries, sports-related accidents, and tumors. 
In the US, acute SCI affects 12,000 individuals every year, and approximately 1 
million people in the US have sustained traumatic spinal cord injuries. Traumatic 
injury to the spinal cord is usually characterized pathologically by a central 
neuronal necrosis surrounded by a region of demyelinated white matter with a 
centrifugal distribution, resulting in sensory, motor, and autonomic dysfunction.  
 
In addition to motor and low-threshold mechanosensory dysfunction, 
approximately two-thirds of patients who have sustained SCI experience slowly 
developing chronic pain after injury (Siddall and Loeser, 2001; Defrin et al., 2002). 
In most cases, SCI-induced chronic pain is termed ‘neuropathic’ since it usually 
results from nervous system injury. Neuropathic pain after SCI can be divided into 
three forms based on the location of pain: most commonly pain is at-level 
(including two segments above and below the lesion level) and below-level (at 
least three segments below the level of injury) relative to the injury site, but above-
level pain is also reported by some patients (Siddall and Loeser, 2001). Patients 
report pain in response to normally innocuous stimuli (allodynia) and in 
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exaggerated form to noxious stimuli (hyperalgesia). This neuropathic pain can be 
devastating, and conventional treatment approaches are often inadequate (Eide, 
1998). Hence, it is urgent to find out the cellular and molecular mechanisms 
underlying post-SCI pain. 
 
1.2. Neurobiology of neuropathic pain 
Noxious stimulation evokes a wide range of physiological changes in the 
organism, resulting in a series of motivational and affective activities designed to 
avoid injury. Specialized primary sensory neurons that detect noxious stimuli are 
termed nociceptors, which usually have high thresholds and activate pathways 
within the central nervous system (CNS, spinal cord and brain) that produce acute 
nociceptive pain, helping to protect individuals from dangerous input. In addition to 
exciting pain pathways, noxious stimulation also activates ascending and 
descending modulatory systems that can increase or decrease the gain of pain 
pathways (Woolf and Salter, 2000).  
 
Dorsal root ganglion (DRG) neurons and the associated primary afferent fibers 
in peripheral nerves comprise the first stage of the pain pathway, carrying 
information in multiple sensory modalities (chemical, thermal, mechanical) from 
the periphery to the spinal dorsal horn. DRG neurons differ in soma size, 
excitability characteristics, and central projections. Certain types of DRG neurons 
and their afferent fibers, primarily thinly myelinated Aδ- and unmyelinated C-fiber 
afferents, generally are considered to be nociceptors and are capable of initiating 
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nociceptive reflexes and pain sensation upon noxious stimulation (Harper and 
Lawson, 1985; Slugg et al., 2000; Dirajlal et al., 2003).  
 
Nociceptive pain is usually transient. However, under various pathological 
conditions, such as peripheral inflammation and nerve injury, pain can be long 
lasting. An important contribution to pain in these cases is made by nociceptors, 
which can be sensitized to respond to innocuous stimuli and fire spontaneously, 
thereby contributing to the development and maintenance of persistent pain, 
including neuropathic pain (Baron, 2006; Djouhri et al., 2006; Hucho and Levine, 
2007; Gold and Gebhart, 2010). Electrophysiologically, nociceptor sensitization is 
characterized by hyperexcitability (including spontaneous activity), and 
hypersensitivity (decreased threshold for activation by thermal, mechanical, and 
chemical stimuli, and increased response to supra-threshold stimuli). These 
abnormal electrophysiological activities may drive spontaneous pain, allodynia, 
and hyperalgesia.  
 
Neuropathic pain is currently defined by the International Association for the 
study of Pain as "pain arising as direct consequence of a lesion or disease 
affecting the somatosensory system" (Treede et al., 2008). It has been reported 
that the same disease entity (e.g. peripheral nerve injury) can cause completely 
different pain symptoms in patients (Fields et al., 1998). Moreover, patients 
suffering from different neuropathic pain syndromes may present similar sensory 
signs (Baron et al., 2009; Scholz et al., 2009), indicating that multiple mechanisms 
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are probably involved in the generation of neuropathic pain (Price et al., 1989; 
Westermann et al., 2012). The mechanisms underlying neuropathic pain have 
been extensively studied in peripheral nerve injury models. Nerve fibers signaling 
nociceptive information that are axotomized by peripheral nerve injury (and 
sometimes by SCI) have compromised nociceptive function. Thus, the induction of 
chronic pain after neural injury suggests the occurrence of qualitative changes in 
some pain pathways. However, in pain pathways that have not been axotomized 
during bodily injury, nociceptive function often increases (Amaya et al., 2003; Gold 
and Gebhart, 2010). 
 
Several mechanisms have been proposed for the initiation and maintenance of 
chronic pain induced by peripheral nerve injury. Enhanced neuronal activity 
occurring in primary afferents is widely assumed to be at the core of neuropathic 
pain (Gold and Gebhart, 2010; von Hehn et al., 2012). Specific environmental 
stimuli (including thermal, mechanical, and chemical stimuli) are encoded into 
membrane potential changes by activating ion channels expressed in sensory 
neuron terminals. It has been demonstrated that nerve injury-induced 
hyperexcitability of primary sensory neurons could result from upregulation of 
several ion channels enriched in nociceptors. For example, transient receptor 
potential vanilloid 1 (TRPV1) channels, which are expressed most abundantly in 
subtypes of small primary sensory neurons and are activated physiologically by 
various noxious stimuli, are upregulated in DRG and uninjured C fibers after a 
nerve injury, contributing to nerve injury-induced heat hyperalgesia and 
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mechanical allodynia (Hudson et al., 2001; Kanai et al., 2005; Kim et al., 2012). In 
addition, the expression of TRPV1 may be induced in large, low-threshold sensory 
neurons, which normally do not express TRPV1 (Hong and Wiley, 2005; Pabbidi et 
al., 2008). Nerve injury also induces upregulation of fast sodium channel Nav1.3, 
and dysregulation of the function or synthesis of slowly inactivating voltage-gated 
Na+ channels (especially tetrodotoxin (TTX)-resistant channels) (Dib-Hajj et al., 
1996; Dib-Hajj et al., 1998; Kral et al., 1999; Bongenhielm et al., 2000; Sleeper et 
al., 2000), as well as potassium channels (Everill and Kocsis, 1999; Yang et al., 
2004). In addition, peripheral nerve injury induces pathological alterations within 
the central nervous system at spinal and supraspinal levels by: 1) sensitization of 
central neurons involving pathological cellular alterations (Latremoliere and Woolf, 
2009); 2) microgliosis and astrogliosis in the spinal cord (Scholz and Woolf, 2007; 
Gao and Ji, 2010); 3) alteration of inhibitory and excitatory transmission of 
nociceptive signals (Coull et al., 2005; Aira et al., 2012); 4) anatomic 
reorganization in central neuronal networks (Lekan et al., 1996). 
 
1.3. Multiple sites are altered after SCI, including DRG 
Spinal cord injury also causes long-lasting alterations at multiple sites along the 
pain pathway (Hains et al., 2003; Hains et al., 2005; Hains and Waxman, 2006; 
Zhao et al., 2007; Carlton et al., 2009; Bedi et al., 2010). Most research into the 
mechanisms underlying SCI-induced chronic pain has focused on injury-induced 
plasticity occurring in both glial cells and dorsal horn neurons (see below). The 
GABAergic system is an essential component in spinal nociceptive processing. 
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The predominant inhibitory neurotransmitter, γ-aminobutyric acid (GABA), in the 
adult CNS generally hyperpolarizes the membrane potential through GABAA 
receptors, and thus decreases neuronal activity. However, SCI disrupts this 
pathway in two ways: 1) SCI induces an apparent loss of GABAergic interneurons 
in the superficial dorsal horn, resulting in reduced inhibitory GABAergic tone and 
chronic pain (Meisner et al., 2010); 2) GABA excites rather than inhibits superficial 
dorsal horn neurons in SCI animals because of a depolarized shift of the Cl- 
equilibrium potential (Lu et al., 2008). Also, a descending antinociceptive 
serotonergic pathway is disrupted in animals displaying behaviorally expressed 
hypersensitivity (Bruce et al., 2002). Morphological evidence indicates that SCI 
enhances dendritic spine length and density (Tan and Waxman, 2012), suggesting 
enhancement of synaptic functions. Furthermore, elevated expression of voltage-
gated sodium channel Nav1.3 has been implicated in SCI-induced 
hyperexcitability of dorsal horn nociceptive neurons as well as pain-related 
behaviors (Hains et al., 2003). In addition, SCI induces activation of microglial cells 
in the CNS (Hains and Waxman, 2006), which along with activation of astroglia 
spreads beyond the injury site in the spinal cord and thalamus (Zhao et al., 2007; 
Detloff et al., 2008; Carlton et al., 2009), resulting in greatly enhanced activity of 
dorsal horn neurons (Hains and Waxman, 2006) and ventral posterolateral 
neurons in the thalamus (Zhao et al., 2007). Intrathecal infusion of minocycline, a 
non-specific microglia inhibitor, prevents the SCI-induced hyperexcitability of 
lumbar dorsal horn neurons (Hains and Waxman, 2006) and relieves (Hains and 
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Waxman, 2006; Marchand et al., 2009) or preemptively reduces (Tan et al., 2009) 
reflexive signs of SCI pain in rodent models.  
 
The possible contribution of primary sensory neurons to SCI-induced chronic 
pain has been neglected until recently. Importantly, all of the alterations described 
in the spinal cord and brain might be driven, at least partly, by enhanced activity in 
primary afferent neurons. Cytokines and inflammatory factors released from 
activated microglia and astrocytes in the spinal cord will reach not only lamina I 
and II neurons that are the postsynaptic targets of DRG neurons, but also 
presynaptic terminals of the DRG neurons in the dorsal horn. In addition, SCI can 
cause inflitration of macrophages and T-cells into widespread DRG (McKay and 
McLachlan, 2004). Thus, SCI-induced pathologic effects may not be limited to the 
CNS, and may directly influence primary sensory neurons. This possibility is 
supported by both morphological and physiological evidence. For example, 
cultured small and medium-sized neurons dissociated from lumbar and thoracic 
DRG show enhanced elongating growth in vitro 3 days after T10 contusion (Bedi 
et al., 2012). Sprouting of central terminals of primary sensory neurons (especially 
calcitonin gene-related peptide-positive nociceptors) in the spinal cord is observed 
in some SCI models (Helgren and Goldberger, 1993; Krenz and Weaver, 1998; 
Weaver et al., 2001; Ondarza et al., 2003; Zinck et al., 2007; Hou et al., 2009). 
Electrophysiological evidence indicates that the function of TTX-sensitive Na+ 
channels is enhanced after SCI in dissociated sensory neurons innervating the 
bladder (Yoshimura and de Groat, 1997). Also, contusive SCI at T10 results in 
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increased spontaneous activity (SA) of nociceptors recorded from rat forelimb 
median nerves in an isolated skin-nerve preparation, and the recorded units show 
sensitized responses to mechanical and thermal stimulation of the skin (Carlton et 
al., 2009). Furthermore, recent work from our laboratory indicates that chronic SA 
intrinsic to the cell bodies of primary sensory neurons (both in vivo and in vitro) 
occurs in widespread DRG of rats with SCI. Most of the isolated DRG neurons 
displaying SA are small, capsaicin sensitive, and bind isolectin B4 (IB4), indicating 
that these neurons are nociceptors (Bedi et al., 2010). However, the molecular 
mechanisms of this persistent nociceptor SA and hyperexcitability following SCI 
are unknown. 
 
1.4. Hyperexcitability of primary nociceptors appears to be an important 
mechanism underlying chronic pain after SCI 
It has been demonstrated that the generation of SA in large diameter DRG 
neurons depends on spontaneous subthreshold oscillations of membrane 
potential (Devor, 2009). Only DRG neurons with spontaneous oscillations of 5 
mV or more at normal resting membrane potentials can generate SA. In contrast, 
DRG neurons without subthreshold oscillations may also generate action 
potentials during depolarizing stimulation, but the spiking is not sustained during 
continued depolarization. Moreover, DRG neurons with subthreshold oscillations 
often have a depolarized resting potential as compared to the neurons without 
oscillations (Amir et al., 1999). Thus, the oscillations repeatedly draw the resting 
membrane potential toward threshold and cause DRG neurons to fire 
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spontaneously. It is not known if small DRG neurons also exhibit spontaneous 
subthreshold oscillations of membrane potential that drive spontaneous firing. 
 
Under neuropathic conditions, the expression and kinetics of ion channels 
may be changed and background oscillations enhanced, increasing the 
proportion of DRG neurons with spontaneous subthreshold (and suprathreshold) 
oscillations of membrane potentials, elevating SA in these neurons. For example, 
peripheral nerve injury greatly increases the proportion of Aβ neurons that display 
subthreshold oscillations and SA (Study and Kral, 1996; Amir et al., 1999). As 
discussed above, contusive SCI at T10 caused increased SA in small diameter 
nociceptors recorded from the forelimb median nerve, lumbar dorsal roots, and 
dissociated small DRG neurons (Carlton et al., 2009; Bedi et al., 2010). We 
observed that SA in nociceptors was associated with membrane depolarization 
(about 5 mV) as compared to silent neurons (Bedi et al., 2010). Similar to what 
was observed in large DRG neurons in a peripheral nerve injury model (Study 
and Kral, 1996), small DRG neurons with SA after SCI exhibited more negative 
thresholds for triggering action potentials, and displayed more repetitive firing 
when depolarizing pulses were applied (Bedi et al., 2010). This suggests that any 
additional small inward currents (such as currents produced by opening of 
transient receptor potential [TRP] channels) should enhance subthreshold 
oscillations and increase the probability of triggering action potentials, thus 
enhancing SA and increasing the excitability of nociceptors. 
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The increased SA incidence of DRG neurons was significantly correlated with 
above-, at- and below-level behavioral hypersensitivity (Bedi et al., 2010). Both 
mechanical and thermal hypersensitivity for hindlimb responses was significantly 
correlated with SA incidence in neurons sampled from L4/L5 DRG. Furthermore, 
SA in the neurons dissociated from above-level (T8, T9, C6, and C7) DRG was 
correlated with behaviorally expressed forelimb hyperreflexia. Significant 
correlations between the enhanced vocalization and incidence of SA in sensory 
neurons dissociated from at- and above-level DRG was also observed during 
responses to at-level and above-level stimuli. The correlation with vocalization 
suggests that SA in DRG neurons might also enhance supraspinally mediated 
responses (including emotional and cognitive components of pain) after SCI. 
Strong evidence for the behavioral importance of SA in nociceptors has come from 
a recent, unpublished study (Yang et al., 2012). We found that eliminating SA in 
most nociceptors in the lumbar region can potently reduce SCI-induced 
hypersensitivity of hindlimb withdrawal responses. This was accomplished by 
intrathecal injection of oligodeoxynucleotides (ODN) antisense to Nav1.8 (Lai et 
al., 2002). Nav1.8 is a voltage-gated Na+ channel that is widely expressed in 
primary sensory neurons, and preferentially (although not exclusively) expressed 
in nociceptors (Dib-Hajj et al., 1998; Shields et al., 2012). Furhermore, Nav1.8 is 
necessary for SA generated in neuromas after peripheral nerve transection (Roza 
et al., 2003). We found that injection of ODN antisense to Nav1.8 selectively 
knocked down Nav1.8 protein expression, reduced corresponding inward currents, 
and eliminated SA in dissociated nociceptors while reversing behavioral signs of 
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hindlimb hypersensitivity following SCI. Mismatched control ODNs had no effect 
(Yang et al., 2012). These exciting findings strongly suggest that nociceptor SA 
and hyperexcitability make major contributions to chronic pain after SCI. 
 
1.5. TRPV1 in nociceptors is potentially involved in SCI chronic pain 
SCI-induced chronic pain includes both spontaneous and evoked pain. 
Interestingly, SCI patients describe their spontaneous pain most commonly as 
“burning” (Cruz-Almeida et al., 2009). Moreover, both noxious heat and innocuous 
cold evoke enhanced pain behaviors in rodent models of SCI (von Heijne et al., 
1999; Carlton et al., 2009; Bedi et al., 2010), as well as in SCI patients (Dykes et 
al., 2006; Felix and Widerstrom-Noga, 2009). This suggests that temperature-
sensitive ion channels may contribute to SCI-induced chronic pain. Particularly 
important in this regard are the TRP channels, a family of cation-conducting 
channels characterized by six-transmembrane domains with cytoplasmic N- and 
C-termini (Tominaga, 2007). Several members of this family respond to moderate 
to noxious temperature changes, including TRPV1, transient receptor potential 
vanilloid-4 (TRPV4) and transient receptor potential ankyrin-1 (TRPA1) 
(Tominaga, 2007). 
 
TRPV1 was the first mammalian TRP channel to be cloned (Caterina et al., 
1997). It is a nonselective cation channel, highly permeable to Ca2+, that is opened 
by capsaicin, noxious heat, protons, and numerous lipid mediators, including 
anandamide and lipoxygenase products (Tominaga, 2007). Although TRPV1 
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channels are expressed in other parts of the nervous system as well (Cui et al., 
2006; Cavanaugh et al., 2011; Kim et al., 2012), their expression levels are by far 
the highest in primary polymodal nociceptors (Tominaga, 2007). TRPV1 appears 
to play an important role in controlling the excitability of nociceptors under some 
pathologic conditions. It has been demonstrated that a proportion of primary 
afferents from C57BL6 mice exhibits peripherally generated SA, and the incidence 
of SA is inversely correlated with threshold for activation by heat (Banik and 
Brennan, 2009). Primary afferents are sensitized and exhibit elevated SA following 
plantar incision injury, which can be dramatically attenuated by genetic deletion of 
TRPV1 (Banik and Brennan, 2009). Also, we found that, after SCI, 80% of 
dissociated small DRG neurons exhibiting SA after dissociation were responsive to 
capsaicin (Bedi et al., 2010). The importance of TRPV1 in various forms of chronic 
pain has been strongly suggested by several lines of evidence: 1) while acute 
withdrawal responses to heat stimulation were still present in TRPV1-/- mice, 
these mice failed to develop thermal hyperalgesia upon inflammatory treatment 
(Davis et al., 2000); 2) systemic administration of TRPV1 antagonists reversed 
signs of heat hyperalgesia in an inflammatory pain model by actions primarily on 
peripheral fibers of nociceptors (Cui et al., 2006); and 3) TRPV1 channels were 
upregulated in DRG neurons from rats showing heat hyperalgesia after peripheral 
inflammation or nerve injury (Hudson et al., 2001; Fukuoka et al., 2002; Ji et al., 
2002; Breese et al., 2005; Kanai et al., 2005).   
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1.6. Several factors modulating TRPV1 channels are elevated after spinal 
cord injury 
The endogenous activators of TRPV1 are uncertain. However, both native and 
cloned TRPV1 channels have been shown to be activated by endogenous 
cannabinoid receptor agonist, anandamide, and metabolites of arachidonic acid 
(AA) (Zygmunt et al., 1999; Hwang et al., 2000; Watanabe et al., 2003). The 
primary sequences of TRPV1 predict many putative phosphorylation sites for a 
variety of protein kinases, including protein kinase C (PKC) (Numazaki et al., 
2002; Peng et al.), which is activated by a lipid product diacylglycerol (DAG). 
TRPV1 channel activity can be enhanced by PKC (Cesare et al., 1999; Numazaki 
et al., 2002; Mandadi et al., 2006; Cao et al., 2009). Moreover, both PKC and DAG 
have been shown to activate TRPV1 directly (Premkumar and Ahern, 2000). As 
TRPV1 is generally inhibited by phosphatidylinositol 4,5-bisphosphate (PIP2), 
reduction of PIP2 during its conversion to DAG by activated phospholipase C may 
also promote TRPV1 channel activity  (Amadesi et al., 2004; Dai et al., 2004; Dai 
et al., 2007). 
 
Such lipid species are signaling molecules playing important roles in multiple 
physiological responses. Accumulation of these lipid products in pathological 
conditions, however, results in extensive stimulation/modulation of their targets 
that can change the excitability of nociceptors and induce pain. It has been 
demonstrated that injection of complete Freund's adjuvant induces DAG 
accumulation in the spinal cord (Fuchs et al., 2004). Also, activated PKC increases 
	   14	  
in the spinal cord dorsal horn following nerve injury (Mao et al., 1992), and PKC 
manipulation modifies thermal hyperalgesia and mechanical allodynia (Coderre, 
1992; Hua et al., 1999). Inflammatory proteases cleave and activate protease-
activated receptor 2 (PAR2) in a subset of primary afferent neurons. TRPV1 can 
be activated downstream of PAR2 via the PLC/PIP2/PKC signaling pathway and 
cause inflammatory pain (Amadesi et al., 2004; Dai et al., 2004; Dai et al., 2007; 
Grant et al., 2007). Also, it has been demonstrated that SCI induces excessive 
accumulation of AA in the spinal cord in a phospholipase A2-dependent manner 
(Liu and Xu, 2010). Lipid signals generated in the spinal cord might activate 
TRPV1 channels in the central processes of DRG neurons, as well as TRPV1 
channels in dorsal horn neurons (see Chapter 7). Such lipid products can be 
produced in response to nerve growth factor (NGF), cytokines and chemokines, 
which are elevated in the spinal cord and/or DRG after SCI (Bakhit et al., 1991; 
Bartholdi and Schwab, 1997; Murakami et al., 2002; Brown et al., 2004).  
 
TRPV1 channel currents induced by endogenous lipid products may be too 
small  to induce spontaneous activity in DRG neurons (Shin et al., 2002) under 
physiological conditions. However, as discussed above, nociceptors with SA are 
relatively depolarized and exhibit reduced thresholds for triggering action 
potentials (Study and Kral, 1996; Bedi et al., 2010). Under these conditions, any 
additional small inward currents may convert the subthreshold oscillations to 
action potentials, thus significantly enhancing SA and hyperexcitability of 
nociceptors. In contrast, larger inward currents may lead to membrane 
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depolarization sufficient to inactivate sodium channels, reducing electrical activity 
of nociceptors (Wu and Pan, 2007).  
 
1.7. TRPV1 antagonists may block SCI chronic pain 
As discussed above, TRPV1 channel upregulation, resulting from increased 
synthesis, and sensitization by lipid products is likely to contribute to intrinsic 
SA/hyperexcitability of nociceptors and subsequent pain behaviors. TRPV1 
channels are Ca2+ permeable (Tominaga, 2007). As a second messenger, Ca2+ 
plays an essential role in controlling many neuronal processes, including 
neurotransmitter release, excitability, gene expression, development, repair, and 
apoptosis.  Thus, activity of TRPV1 channels can result in at least four 
consequences: 1) direct depolarization of DRG neurons to elicit 
SA/hyperexcitability; 2) direct and/or indirect increase in intracellular Ca2+ 
concentration, which will enhance neurotransmitter release and amplify peripheral 
input to pain projection neurons in the dorsal horn; 3) synergism with other pain-
related signals, such as those promoting translocation of PKC to the plasma 
membrane (Oancea and Meyer, 1998); and 4) enhancement of pain-related 
protein expression. Thus, enhanced activity of TRPV1 channels may contribute to 
both the development and maintenance of post-SCI pain.  
 
In addition to their extensive expression in primary sensory neurons TRPV1 
channels have also been reported in spinal dorsal horn neurons where they are 
thought to contribute to the maintenance of pain (Zhou et al., 2009; Wei et al., 
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2010; Kim et al., 2012), although the occurrence and significance of TRPV1 
expression in the spinal cord is controversial (Caterina et al., 1997; Cui et al., 
2006; Cavanaugh et al., 2011; Kim et al., 2012) (see Chapter 7). In this regard, 
systemic application of A-784168 (Abbott Laboratories, Abbott park, IL), a TRPV1 
antagonist with good blood-brain barrier penetration, demonstrates a more potent 
reduction of mechanical allodynia than A-795614 (Abbott laboratories), a 
peripherally restricted TRPV1 antagonist, although both antagonists show similar 
potency on thermal hyperalgesia in a peripheral inflammatory pain model (Cui et 
al., 2006). This difference could be explained by effects of the antagonist on 
central synaptic terminals of primary nociceptors as well as effects on dorsal horn 
neurons. Increased expression of TRPV1 has been reported in the spinal cord 
following SCI using both immunohistochemistry and RT-PCR methods (Zhou et 
al., 2002; DomBourian et al., 2006).  Thus, targeting TRPV1 channels expressed 
both peripherally and centrally may optimize analgesic effects. 
 
Anti-hyperalgesia effects induced by antagonists of TRPV1 have been 
observed in various rodent pain models (Gavva et al., 2005; Cui et al., 2006; Yu et 
al., 2008). For example, AMG9810 (i.p. and intrathecal), a specific TRPV1 
antagonist, significantly relieves behaviorally expressed mechanical and heat 
hypersensitivity in an inflammatory pain model (Gavva et al., 2005; Yu et al., 
2008). These findings indicate that the TRPV1 channel is involved not only in the 
maintenance of thermal hyperalgesia as discussed above, but also mechanical 
allodynia. SCI produces both mechanical allodynia and thermal hyperalgesia. 
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Thus, targeting TRPV1 may reduce nocifensive behaviors and pain following SCI. 
Indeed, the TRPV1 antagonist AMG9810 has been reported to reduce thermal 
hyperalgesia following SCI (Rajpal et al., 2007). Thus, TRPV1 channels could be 
attractive targets for treating post-SCI pain.  
 
1.8 Hypotheses 
The observations reviewed above lead to my general hypothesis: chronic pain 
induced by SCI is maintained by SA in nociceptors, and this nociceptor SA 
is promoted by increased TRPV1 function. This general hypothesis contains 
two specific hypotheses that were tested in this dissertation: 
 
Hypothesis 1.  SCI increases the expression and function of TRPV1 in primary 
nociceptors. 
 
Hypothesis 2. Enhanced TRPV1 function contributes to intrinsic SA and 
hyperexcitability of primary nociceptors.  
 
Hypothesis 2.  Behaviorally expressed hypersensitivity to heat and mechanical 
stimuli following SCI can be reduced by attenuating TRPV1 activity. 
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CHAPTER 2: Material & Methods 
 
2.1. Animals 
A total of 112 rats (62 SCI, 22 sham-treated, 28 naïve) were used in these 
studies. All procedures conformed to the guidelines of the International 
Association for the study of Pain, and were approved by the Animal Care and Use 
Committee of the University of Texas Medical School at Houston. Male, adult, 
Sprague-Dawley rats (200-300g) were used in this study. Animals were housed 2 
per cage in a controlled environment (12 hour reversed light/dark cycle, 21 ± 1°C) 
with standard food and water. The rats were allowed to adjust to their environment 
for a week before tests began (Fig.1). 
 
2.2. Spinal cord injury 
Rats were anesthetized with ketamine (80 mg/kg), xylazine (20 mg/kg) and 
acepromazine (0.75 mg/kg). Animals received a laminectomy at T10 (Fig. 2) 
followed by a spinal contusion using the Infinite Horizons impactor (150 kdyne, 1 s 
dwell time) using procedures based on described methods (Dulin et al., 2013). 
Sham-treated animals received the laminectomy and identical treatment except for 
the spinal impact. The surgical site was flushed with 1 ml of normal saline. The 
overlying muscles were replaced over the spine and the skin incision was then 
stapled with wound clips. Cages containing rats were then placed on a heating 
pad to maintain body temperature at ∼37 °C for 24 hours. Food and water 
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Figure 2. Schematic diagram illustrating the contusion site at T10. 	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were placed within easy reach to permit eating and drinking easily without 
assistance. Animals then received twice daily injection (i.p.) of lactated Ringers 
solution (2 ml) and analgesic (buprenorphine; 0.02 mg/kg, i.p.) for 5 days post-
injury and prophylactic antibiotics (Baytril, 2.5 mg/kg) for 10 days. Manual bladder 
evacuations were performed twice daily until neurogenic bladder voiding returned. 
Possible signs of spontaneous pain, including marked inactivity, excessive 
grooming, and autotomy were noted. Autotomy is rare in the spinal contusion 
model, and the very few animals exhibiting severe autotomy (n = 3) were 
euthanized immediately. 
 
2.3. Dissociation and culture of DRG neurons 
After rats were intracardially perfused with cold PBS under deep anesthesia 
(Beuthanasia, 75 mg/kg, i.p.), the thoracic and lumbar segments of the vertebral 
column were removed. A laminectomy was performed to expose lumbar DRG, and 
L4 and L5 DRG were then removed. The excised ganglion was minced, and the 
fragments transferred into Dulbecco’s modified eagle medium (DMEM, Invitrogen, 
Grand Island, NY) containing collagenase (0.6 mg/ml, Roche, Mannheim, 
Germany) and trypsin (0.4 mg/ml, Worthington, Lakewood, NJ), and incubated 40 
min at 34oC. The cells were spun down and transferred to 35 mm Petri dishes 
containing poly-L-lysine (50 mg/ml)-precoated cover glass (8 mm, Warner 
Instruments, Hamden, CT) and incubated with DMEM (without serum) at 37oC in 
5% CO2 overnight. After 18-24 h incubation, living cells were digitally imaged and 
recorded. 
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2.4. In vitro recording of DRG neurons 
Electrodes with a resistance of ~2 MΩ were pulled from BF150-86-10 glass 
capillaries (inner diameter, 0.86 mm; outer diameter, 1.5 mm; Sutter Instrument 
Co, Novato, CA) using a micropipette puller (P-2000, Sutter Instrument Co, 
Novato, CA). Neurons were visualized using differential interference contrast (20 
x) optics on an inverted microscope (Axiovert 200M, Zeiss Oberkochen, 
Germany).  Images of cells were taken with a CCD camera.  Neurons (soma 
diameter < 30 µm) were recorded in the whole-cell configuration using an EPC-10 
amplifier (HEKA Instruments, Lambrecht, Germany).  After forming a tight seal (> 1 
GΩ) the membrane was ruptured. After the whole-cell configuration was 
established, the cell membrane capacitance and series resistance were 
electronically compensated.  In current-clamp mode resting membrane potential 
(RMP) and any SA were recorded. Under whole-cell voltage-clamp capsaicin 
responses were recorded. All experiments were performed at room temperature 
(~23 °C).  Signals were digitized at 2-20 kHz (depending on the duration of 
recording), and acquired using the Pulse software program (HEKA). The pipette 
solution contained (in mM) 134 KCl, 1.6 MgCl2, 13.2 NaCl, 3 EGTA, 9 HEPES, 1 
Mg-ATP, and 0.3 Na-GTP (pH 7.2 adjusted with KOH, osmolarity 300 mOsM).  
The bath solution contained (in mM) 140 NaCl, 3 KCl, 1.8 CaCl2, 2 MgCl2, 10 
HEPES, 10 Glucose (pH 7.4 adjusted with NaOH, osmolarity 320 mOsM). For 
perforated patch recordings, the pipette was initially filled with regular pipette 
solution by brief immersion, and the remainder of the pipette was back-filled with 
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pipette solution containing gramicidin. A 50 mg/ml gramicidin solution was 
prepared in DMSO, and then diluted to a final concentration of 100 µg/ml in the 
pipette. 
 
2.5. Calcium imaging 
Intracellular free Ca2+ concentration was measured using Fura-2 fluorescent 
indicator as described previously (Wu et al., 2007). Dissociated DRG neurons 
were incubated in 5 µM Fura 2-AM (Calbiochem, Darmstadt, Germany) in 
extracellular solution for 20 min and then washed 4 times in the dark at room 
temperature. Fluorescence images were acquired with a Hamamatsu C2400 
iCCD. Quantitative measurements of [Ca2+]i in DRG neuron somata were made 
with an InCyt Im2 Fluorescence Imaging System (Intracellular Imaging) equipped 
with a PixelFly CCD camera (Cooke). R, the ratio of the fluorescence intensity 
(511 nm), was obtained upon excitation at 340 nm and 380 nm for each cell of 
interest. 
 
2.6. Drug application: 
Drugs were dissolved in distilled water at 1,000 times their final concentration 
and kept frozen in aliquots except for capsaicin, AMG9810 (Amgen, Thousand 
Oaks, CA), and Fura 2-AM, which were prepared as stock solutions dissolved in 
ethanol and DMSO, respectively.  The stock solutions were diluted in extracellular 
or intracellular solution just before use and held in a series of independent 
syringes connected to an array of corresponding fused silica columns (inner 
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diameter, 200 µm).  The exchange of solutions was achieved rapidly by shifting 
the tubes horizontally with a micromanipulator.  The distance from the column 
mouth to the cell examined was about 100 µm.  Cells in the recording chamber 
were continuously bathed in the extracelluar solution.  Each drug solution was 
delivered to the recording chamber by gravity. In vivo delivery of AMG9810 was 
achieved by a single i.p. injection (30 mg/kg, 2 ml).	  Drugs and chemicals were 
purchased from Sigma-Aldrich (St. Louis, MO) except Fura 2-AM (Calbiochem). 
 
2.7. Antisense oligodeoxynucleotide (ODN) delivery 
The sequence of antisense oligodeoxynucleotide (ASO) targeting TRPV1 was 
previously reported (Christoph et al., 2007), which was 5’-
CATGTCATGACGGTTAGG-3’. The sequence for mismatch oligodeoxynucleotide 
(MMO) was 5’-CATGCTATGAGCGTTGAG-3’. This ASO induces nearly complete 
degradation of TRPV1 mRNA, and can be taken up well in vivo by DRG neurons 
after intrathecal delivery (Christoph et al., 2007).	  Oligonucleotides (ODN) were 
purchased from Sigma-Aldrich. 1 month after SCI, rats were anesthetized using an 
isoflurane/oxygen mixture.  A chronically indwelling intrathecal catheter (PE-10, 
Becton Dickinson, Sparks, MD) was implanted through a dural slit over the 
atlantooccipital joint (Yaksh and Rudy, 1976). The catheter terminated at the 
lumbar enlargement (Fig. 3). After catheterization, rats were housed individually 
and allowed to recover for at least 5 days before the injection. ODN were injected 
during brief isoflurane sedation twice daily for 3 days, and then once per day for 2 
days, with 45 µg ODN in 5 µl saline injected each time, followed by a 10 µl saline 
	   25	  
Figure 3. An intrathecal catheter was surgically implanted in contusive rats 
to permit intrathecal ODN administration. The PE-10 14-cm long catheter 
was inserted into the subarachnoid space and passed along the posterior 
aspect of the spinal cord to reach the lumbar area for ODN delivery.  	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flush. Tip location and patency were verified post-mortem. 
 
2.8. Western blotting 
1 month after surgery or 5 days after the knockdown procedure, animals were 
anesthetized with Beuthanasia and perfused with ice-cold PBS. Four DRG 
(bilateral L4, L5) from each rat were removed and immediately placed on dry ice. 
DRG were homogenized in 300 µl lysis buffer (RIPA, Teknova) containing 
protease inhibitor cocktail (Sigma). After homogenization, samples were sonicated 
3 times (10 s pulse), and centrifuged at 14,000 rpm for 10 min at 4oC. Protein 
concentration of lysates was determined by the BCA method (Pierce BCA Protein 
Assay Kit). Samples were prepared for SDS-PAGE (Bio-Rad, 4-20% Tris-HCl) by 
1:1 dilution with Laemmli buffer and 30 µg proteins were loaded in each well. After 
electrophoresis, the gel was transferred to a PVDF membrane and blocked with 
10% nonfat dry milk prior to incubation with antibody against TRPV1 overnight at 
4oC. The membrane was incubated with anti-rabbit or anti-mouse IgG for 1h at 
room temperature, developed using the ECL kit (Pierce), and scanned. Protein 
expression was quantified by optical density using Image J software (NIH). Color 
molecular weight standards were run on each gel. β-actin was used as a loading 
control.  
 
2.9. Behavioral tests 
To monitor effects of SCI on hindlimb motor function, animals were placed in 
an open field (child's pool) and their spontaneous behavior videotaped in white 
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light and scored on the 22-point Basso, Beattie, Bresnahan (BBB) locomotor rating 
scale (Basso et al., 1996). Animals accepted for this study exhibited BBB scores in 
the range of 0-1 one day after SCI. Behavioral sensitivity data were collected 
during the animals’ active phase in red light and analyzed using blind procedures.	  
Animals received a standard 5 day sequence of tests for behaviorally expressed 
hyperreflexia prior to impact and then before and after AMG9810 or ODN delivery, 
as we described previously (Bedi et al., 2010). Prior to each test, the animals were 
habituated for 20 min in each of the testing chambers on day1, and received the 
mechanical and thermal test stimuli on days 2 and 3 to habituate to the test 
procedures. Data were collected during the same tests on days 4 and 5.	  Below-
level signs of heat hypersensitivity were tested with the Hargreaves radiant heat 
method using an IITC Plantar Analgesia Meter (Woodland Hills, CA) to measure 
the latency to hindpaw withdrawal. The heat stimulus ended after 20 s stimulus if 
no response occurred to prevent possible tissue injury. Both left rear and right rear 
hindpaws were tested at 5 min intervals. This test sequence was repeated 2 times, 
at 20 min intervals. Below-level signs of mechanical hypersensitivity (decreased 
threshold) were tested with a single series of calibrated von Frey filaments 
(Stoelting, Wood Dale, IL) delivered to the glabrous surface of the hindpaws 
(Hulsebosch et al., 2000) in a sequence determined by the “up-down” method 
(Chaplan et al., 1994). Only one test series was applied to each hindpaw. 
 
2.10. Data analysis 
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Analyses were performed with Sigmaplot 11 (Systat software, San Jose, CA) 
and Prism 5.0 (Graphpad, La Jolla, CA). Statistical data are presented as means ± 
S.E.M.  All comparisons among different group of animals were tested for 
significance using the Student's unpaired t-test or one-way ANOVA with repeated 
measures followed by Bonferroni’s post-hoc tests.  Paired t-tests were utilized to 
analyze treatment effects in within-animal comparisons. SA incidence among 
different group of animals was compared using Fisher’s exact tests. For all 
statistical analyses, P < 0.05 was considered to be statistically significant. 
Statistically significant differences were indicated in each figure (*, P<0.05; **, 
P<0.01; ***, P<0.001). The n in all experiments indicates the numbers of DRG 
neurons (electrophysiology) or rats (western blot or behavior) tested in each 
condition. 
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CHAPTER 3: SCI enhances TRPV1 channel function in 
nociceptors 
 
3.1. Introduction 
SCI patients describe their spontaneous pain most commonly as “burning” 
(Cruz-Almeida et al., 2009). Moreover, noxious heat evokes enhanced pain 
behaviors in rodent models of SCI (von Heijne et al., 1999; Carlton et al., 2009; 
Bedi et al., 2010), as well as SCI patients (Dykes et al., 2006; Felix and 
Widerstrom-Noga, 2009). This suggests that temperature-sensitive ion channels 
may contribute to SCI-induced chronic pain. Particularly interesting in this regard 
are TRPV1 channels. TRPV1 is a nonselective cation channel that is highly 
permeable to Ca2+ and is opened by capsaicin, noxious heat, protons, and lipid 
mediators, including anandamide and lipoxygenase products (Tominaga, 2007). 
TRPV1 channel expression levels are by far the highest in primary polymodal 
nociceptors (Caterina et al., 1997; Tominaga et al., 1998; Caterina et al., 2000; 
Lauria et al., 2006; Hoffman et al., 2010). After SCI, various factors, including 
cytokines, chemokines, and NGF are elevated in the spinal cord (Bakhit et al., 
1991; Bartholdi and Schwab, 1997; Murakami et al., 2002; Brown et al., 2004). In 
addition to sensitizing spinal dorsal horn neurons and promoting the activation of 
glial cells (Miller et al., 2009), these factors communicate also with central 
terminals of primary sensory neurons, thus potentially regulating the function of 
various ion channels in DRG neurons, including TRPV1. It has been demonstrated 
that CC chemokine ligand 2 (CCL2) increases the current density of TRPV1 
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Figure 4. Comparison of capsaicin-sensitive currents among adult DRG 
neurons dissociated from naïve, sham and SCI rats. A, original current 
traces and summary data show that SCI had no obvious effect on 3 µM 
capsaicin-induced currents as compared to sham treatment 3 days after 
surgery. B, original recordings and summary data show that capsaicin-
induced currents in DRG neurons were increased 1 month after SCI, as 
compared to age-matched naïve and sham rats.  	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 channels in DRG neurons (Kao et al., 2012). Also, TRPV1 channels are 
upregulated in DRG neurons from rats showing thermal hyperalgesia after 
peripheral inflammation or nerve injury (Hudson et al., 2001; Fukuoka et al., 2002; 
Ji et al., 2002; Breese et al., 2005; Kanai et al., 2005). SCI is accompanied by 
persistent inflammatory effects within the spinal cord (Alexander and Popovich, 
2009; Dulin et al., 2013) and within DRG (McKay and McLachlan, 2004; Carlton et 
al., 2009). Little is known about potential TRPV1 alterations after SCI 
(DomBourian et al., 2006; Rajpal et al., 2007), but immunohistochemical evidence 
suggests that SCI increases TRPV1 expression in DRG (Ramer et al., 2012).	  I 
thus hypothesize that TRPV1 channel function is enhanced after SCI. 
 
3.2. Results 
3.2.1. SCI enhances currents evoked by capsaicin 1 month but not 3 days 
after SCI 
Because maximal activity of TRPV1 in DRG neurons dissociated from rats can 
be achieved by 3 µM capsaicin (McIntyre et al., 2001; McLatchie and Bevan, 
2001), I used 3 µM capsaicin to determine the difference in TRPV1 channel 
function among nociceptors dissociated from naïve, sham and SCI animals. The 
diameters for recorded neurons dissociated from naïve, sham and SCI rats were 
23.21 ± 0.33 (n = 88), 21.65 ± 0.51 (n = 67), 22.34 ± 0.43 µm (n = 71), 
respectively. Cells were held at -60 mV under voltage clamp. A 5 s, gravity-fed 
stream of capsaicin (3 µM) was applied ~100 µm from the soma through a fused 
silica column (i.d. 200 µm), and inward currents recorded. A resulting inward 
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current > 40 pA was considered a capsaicin response (Dirajlal et al., 2003). 
Capsaicin-induced currents were significantly increased 1 month, but not 3 days, 
after SCI compared to neurons from sham and naïve animals. At 3 days post-
injury in the SCI, sham and naïve groups, the capsaicin-induced current densities 
were 101.5 ± 24.3 (n = 15), 93.7 ± 20.9 (n = 13), and 100.4 ± 15.0 (n = 27) pA/pF, 
respectively (F2,52 = 0.037; one-way ANOVA, Fig. 4A). In contrast, in DRG 
neurons dissociated from animals 1-2 months after SCI the capsaicin-induced 
current density was significantly higher (218.4 ± 25.6 pA/pF, n = 56) than that 
recorded from age-matched sham (124.1 ± 13.9 pA/pF, n = 54) and naïve (127.7 ± 
10.4 pA/pF, n = 61) groups (F2,168 = 9.091; P < 0.0001, one-way ANOVA, Fig. 4B).   
 
To determine whether SCI alters the distribution of TRPV1 in DRG neurons, I 
compared the proportions of dissociated neurons responding with small but 
reliably detectable inward currents (> 40 pA) among these groups. No differences 
were found among these groups in the percentage of capsaicin sensitive neurons 
(~80%) (Fig. 5A and B). To further investigate the differences of capsaicin-
induced responses in DRG neurons among 1 month SCI, sham, and age-matched 
naïve groups, DRG neurons were grouped according to soma diameters. A 
histogram was plotted to show the capsaicin currents in different diameters among 
these three groups of cells. The largest number of small cells had soma diameters 
of 20-25 µm (Fig. 5C). Most importantly, capsaicin-induced currents were higher in 
DRG neurons from the 1 month SCI group compared to DRG neurons dissociated 
from sham or naïve animals in each diameter range (Fig. 5C). The occurrence of 
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Figure 5. Capsaicin-sensitive currents are not redistributed after SCI. A, 
summary data indicates no differences among 3 day SCI, sham and naïve 
groups in the percentage of small DRG neurons that were sensitive to 
capsaicin. B, summary data indicates that percentage of small DRG neurons 
that were sensitive to capsaicin were not changed following 1 month SCI. C, 
Increased responses after SCI occur similarly in very small neurons (probably 
exclusively C-fiber neurons) and cells that are almost medium-sized 
(probably containing Aδ neurons).   	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 larger capsaicin-induced currents in neurons with diameters in the 26-30 µm 
range suggests that this effect occurs in some Aδ-fiber neurons as well as C-fiber 
neurons (Harper and Lawson, 1985). These results show that currents evoked by 
activation of TRPV1 channels are enhanced by SCI long after the injury. 
 
3.2.2. SCI enhances Ca2+ responses evoked by capsaicin 1 month but not 3 
days after SCI 
The TRPV1 channel is highly permeable to Ca2+ (Caterina et al., 1997), thus, 
alterations in TRPV1 channel function can be reflected by alterations in capsaicin-
induced intracellular Ca2+ responses.  By measuring changes in the Fura-2 
emission ratio, intracellular calcium concentrations can be monitored. Similar to 
what was observed in the electrophysiological recordings, DRG neurons 
dissociated from animals 3 days after SCI showed little alteration in intracellular 
Ca2+ responses to capsaicin delivery  (0.31 ± 0.04, n = 13) as compared to 
responses in neurons from sham (0.34 ± 0.04, n = 14) and naïve (0.34 ± 0.05, n = 
23) animals (F2,37 = 0.8824; Fig. 6A).  However, the change in intracellular free 
calcium concentration evoked by capsaicin (3 µM) was significantly higher in DRG 
neurons dissociated from 1 month SCI (0.69 ± 0.12, n = 19) versus sham (0.41 ± 
0.06, n = 17) and naïve (0.33 ± 0.05, n = 25) animals (F2,51 = 5.606; P = 0.0063, 
one-way ANOVA, Fig. 6B). These results show that Ca2+ entry through TRPV1 
channels is enhanced by SCI long after the injury.  
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Figure 6. Comparison of capsaicin-induced intracellular [Ca2+] change 
among adult DRG neurons dissociated from naïve, sham and SCI rats using 
Fura-2 ratiometric calcium dye. A, representative traces and summary data 
show similar response in DRG neurons isolated from 3 day SCI, age-
matched naïve and sham rats, following capsaicin (3 µM) administration. B, 
representative traces and summary data shown 3 µM capsaicin-induced 
response was significantly enhanced 1 month after SCI. 	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3.3. Conclusions 
3.3.1. TRPV1 channel function is enhanced 1 month following SCI 
These studies show that capsaicin-induced responses are enhanced in small 
and medium-sized DRG neurons 1 month, but not 3 days, after SCI. Capsaicin is a 
selective agonist of TRPV1 channels, and induces a maximal response at 3 µM in 
rat DRG neurons (McIntyre et al., 2001; McLatchie and Bevan, 2001). In my 
studies, TRPV1 channel function was measured by both whole-cell voltage-clamp 
and Ca2+ imaging methods. When TRPV1 channels are opened upon capsaicin 
exposure, the cellular response is largely determined by four factors: 1) the 
number of TRPV1 channels, 2) the activity of individual TRPV1 channels, 3) 
membrane potential, and 4) the Ca2+ and Na+ gradients across the plasma 
membrane. In my voltage-clamp recordings, DRG neurons were hold at -60 mV, 
and the recording solutions were invariant during each experiment and the same 
for all groups. Thus, changes in these currents evoked by maximal doses of 
capsaicin could be caused by changes in the maximal number of available TRPV1 
channels and the responsiveness of each channel in each neuron tested. 
However, SCI also causes chronic depolarization of small DRG neurons that is 
present after dissociation (Bedi et al., 2010). Thus, an interesting question is how 
the capsaicin responses may change after SCI in dissociated neurons that are not 
all clamped at the same holding potential. Thus, I also performed Ca2+ imaging 
experiments to examine TRPV1 channel function at the native resting membrane 
potentials 1 day after dissociation and found that both patch-clamp and Ca2+ 
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imaging experiments yielded similar results: TRPV1 channel function is enhanced 
in small DRG neurons 1 month SCI. 
 
3.3.2. The distribution of TRPV1 in small and medium-sized DRG neurons is 
unchanged 1 month after SCI 
I focused on relatively small DRG neurons with soma diameters ≤30 µm. The 
diameters of sampled neurons were not significantly different among naïve, sham, 
and SCI groups. Alteration of TRPV1 distribution across different sizes of DRG 
neurons has been reported in several chronic pain models. The proportion of 
TRPV1-positive cells among small and medium-sized DRG neuron subpopulations 
was increased in a peripheral inflammatory model, but decreased after 
axotomizing nerve injury (Amaya et al., 2003; Ma et al., 2005; Shinoda et al., 
2008). In addition, SCI can produce hypertrophy of TRPV1-expressing DRG 
neurons measured in situ (Ramer et al., 2012). However, I found that the 
percentage of relatively small DRG neurons responding to capsaicin was 
unchanged after T10 contusion. Furthermore, when I grouped these relatively 
small DRG neurons according to soma diameter, the capsaicin-induced currents 
were consistently higher after SCI than sham treatment or in the naïve group in 
neurons with soma diameters in all parts of this size range. I cannot exclude the 
possibility that TRPV1 is induced in larger DRG neurons by SCI because I did not 
sample DRG neurons  with soma diameters > 30 µm. Large DRG neurons are 
reported to become TRPV1 positive in some peripheral chronic pain models 
(Amaya et al., 2003; Ma et al., 2005; Shinoda et al., 2008). Although larger DRG 
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neurons (including non-nociceptors) might show similar effects after SCI, my data 
support the hypothesis that long-term enhancement of TRPV1 function in small 
DRG neurons (probable nociceptors) is produced by SCI. 
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CHAPTER 4: SCI enhances the expression of TRPV1 protein 
 
4.1. Introduction 
One mechanism that could produce the increases in capsaicin-evoked inward 
currents and Ca2+ transients observed after SCI is increased expression of TRPV1 
channels. TRPV1 channel expression is upregulated in DRG neurons from rats 
showing thermal hyperalgesia after peripheral inflammation or nerve injury 
(Hudson et al., 2001; Fukuoka et al., 2002; Ji et al., 2002; Breese et al., 2005; 
Kanai et al., 2005). SCI is accompanied by persistent inflammatory effects within 
the spinal cord (Alexander and Popovich, 2009; Dulin et al., 2013) and within DRG 
(McKay and McLachlan, 2004; Carlton et al., 2009). Thus, TRPV1 channel activity 
might be enhanced in nociceptors following SCI by increased expression of the 
protein. TRPV1 synthesis and expression are enhanced by NGF through 
activation of the p38 mitogen-activated protein kinase (MAPK) signaling pathway 
(Ji et al., 2002; Puntambekar et al., 2005; Stein et al., 2006). SCI elevates NGF 
levels in the spinal cord (Bakhit et al., 1991; Murakami et al., 2002; Brown et al., 
2004), which has been suggested to contribute to increased TRPV1 staining in the 
superficial dorsal horn (below the injury level) 3-14 days after spinal cord 
transection as compared to sham treatment (Zhou et al., 2002). Elevated NGF 
after SCI may influence primary sensory neurons by binding to receptors on their 
central terminals, thereby stimulating upregulation of TRPV1 in the DRG, and 
contributing to the development of abnormal behavior after SCI (Gwak et al., 
2003). Here I test the hypothesis that SCI increases the expression of TRPV1 
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protein in DRG below the injury level. 
 
4.2. Results 
If DRG neurons respond to the central inflammation caused by SCI in the same 
way that they respond to peripheral inflammation, then TRPV1 channels should 
show increased expression in nociceptor somata in the DRG and in their terminals 
within the dorsal horn. I thus performed Western blot analysis to determine the 
expression levels of TRPV1 protein in DRG harvested bilaterally from segments 
L4 and L5 in each group of rats. A representative result is shown in Fig 7A and the 
relative amounts of TRPV1 protein (normalized to β-actin) obtained 1 month after 
injury in SCI, sham, and naïve groups are plotted in Fig 7B. The amount of TRPV1 
protein was significantly different among DRG excised from naive (n = 6), sham-
treated (n = 5), and SCI (n = 6) animals (F2,14 = 22.93; P < 0.0001), with the levels 
being higher in ganglia from SCI than sham-treated or naive animals. When 
protein levels in DRG from sham-treated and SCI animals were further normalized 
to those of DRG from naive animals run on the same gels, levels from SCI animals 
were significantly greater than those from sham animals (Fig. 7B; P = 0.006, t-
test). This indicates that SCI stimulates an increase in TRPV1 protein in DRG 
neurons 1 month after injury. 
 
4.3. Conclusions 
These results support the hypothesis that at least part of the enhanced 
sensitivity of small DRG neurons to capsaicin after SCI is caused by increased 
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Figure 7. Expression of TRPV1 in rat DRG neurons was upregulated 1 month 
after SCI. Left panel (A) shows western blot bands of TRPV1 and β-actin 
probed with their specific antibodies. β-actin was used as the internal control. 
A total of 5 experiments performed on DRG indicate the relative intensity of 
TRPV1 band increased significantly after 1 month of SCI (B). Intensities of 
TRPV1 bands were first normalized to that of β-actin in each sample and then 
to that value from the paired naïve sample. 	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 expression of TRPV1 channels. In this study, TRPV1 expression was measured 
at the protein level using western blotting, and thus extends immunohistochemical 
evidence for increased expression of TRPV1 in the DRG after SCI (Ramer et al., 
2012). Immunohistochemical results (Ramer et al, 2012; Yang, Wu, and Walters, 
unpublished observations) indicate that the increased expression occurs within 
neurons rather than other cell types in the DRG. The Western blot and 
immunohistochemical studies don't distinguish between channels located in the 
neuronal membrane and in the cytoplasm, but in combination with the results in 
Chapter 3 showing increased TRPV1 activity, the Western blot findings strongly 
suggest that at least some of the increased activity occurs because of a larger 
number of functional channels in the membrane after SCI. My functional data 
(Chapter 3) indicate that the increased expression after SCI occurs, at least in 
part, in small DRG neurons that are probably nociceptors. In naive animals TRPV1 
channels are rarely expressed in large DRG neurons, but a shift of TRPV1 
expression towards large DRG neurons has been reported after peripheral nerve 
injury (Hudson et al., 2001; Ma et al., 2005). After another form of SCI, complete 
low thoracic (T10) spinal cord transection, a shift in expression towards larger 
DRG neurons was not observed (Ramer et al., 2012), suggesting that upregulation 
of TRPV1 channels is largely restricted to smaller DRG neurons. As described in 
Chapter 3, SCI altered capsaicin-induced currents to a similar degree across all 
DRG neurons with soma diameters less than 30 µm. Taken together, these 
observations suggest that enhanced TRPV1 expression in DRG after SCI occurs 
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in a large fraction of C-fiber nociceptors and probably in some Aδ-fiber 
nociceptors. 
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CHAPTER 5: Inhibiting TRPV1 activation reduces SCI-induced 
pain behaviors 
 
5.1. Introduction 
Increased activity of TRPV1 channels, resulting from increased channel 
expression, ongoing activation by endogenous ligands, or modulation by 
intracellular regulators, appears likely to contribute to intrinsic SA in nociceptors 
and consequent pain. TRPV1 channels are Ca2+ permeable (Tominaga, 2007), 
and Ca2+ plays an essential role in controlling many neuronal activities, including 
neurotransmitter release, gene expression, and development. Activity in TRPV1 
channels could have at least four consequences that promote pain after SCI: 1) 
direct depolarization of DRG neurons, bringing membrane potential into a range 
that enhances SA and excitability; 2) direct and/or indirect increase in intracellular 
Ca2+ concentration, which can enhance neurotransmitter release and amplify 
primary afferent input to pain projection neurons; 3) synergism with other signals, 
e.g., by promoting translocation of PKC to the plasma membrane (Oancea and 
Meyer, 1998); and 4) enhancement of pain-related protein expression within 
nociceptors.  
 
Application of TRPV1 channel antagonists, including AMG9810, effectively 
reduces behaviorally expressed thermal and mechanical hypersensitivity in 
various rodent pain models (Gavva et al., 2005; Cui et al., 2006; Yu et al., 2008).  
Although most TRPV1 antagonists produce significant hyperthermia as a side 
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effect, limiting their clinical utility (Gavva et al., 2007; Gavva et al., 2008), recent 
discoveries of antagonists that do not alter body temperature are revitalizing this 
approach for treating chonic pain (Reilly et al., 2012).  
Both mechanical allodynia and heat hyperalgesia develop after SCI, and 
mechanical allodynia is a particularly debilitating problem for many SCI patients 
(Sjolund, 2002). Weak support for TRPV1 channel involvement in SCI-induced 
heat hypersensitivity came from a very small preliminary study (lacking control 
groups) claiming that AMG9810 reduces thermal hypersensitivity following SCI 
(Rajpal et al., 2007). Although differences were not found between “hyperalgesic” 
and “non-hyperalgesic” animals in that study, less than 50% of the animals 
exhibited SCI-induced decreases in withdrawal latency during heat stimulation 
(possibly because systematic habituation to the context and stimuli were not 
performed before data collection), which is much less than typically found in our 
laboratory (Bedi et al., 2010), Here, I will rigorously test the hypothesis that 
continuing TRPV1 activity is important for chronic behavioral hypersensitivity after 
SCI. 
 
5.2. Results: 
5.2.1 Systemic injection of AMG9810 ameliorates SCI-induced heat and 
mechanical hypersensitivity of hindlimb withrawal responses  
In principle, enhancement of TRPV1 channel function in nociceptors after SCI 
would be expected to contribute to SCI-induced chronic pain. I have tested the 
effects of in vivo application of AMG9810, a specific TRPV1 antagonist (Gavva et 
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al., 2005), on behaviorally expressed hindlimb hypersensitivity (Fig. 8A, B). Before 
contusion, each animal received behavioral pretests (thermal and von Frey stimuli 
applied to plantar surface). One month after SCI, the same tests were performed 2 
days before injection, at which time behavioral sensitivity increased to both heat 
(from 14.17 ± 0.77 to 7.67 ± 0.69 s, n = 6) and mechanical  (8.59 ± 1.90 to 3.02 ± 
0.79 g, n = 7) test stimuli. Animals then received either AMG9810 (30 mg/kg, i.p.) 
or vehicle (saline with 0.1% DMSO, 2 ml, i.p.). Posttests were performed 30 min 
after each injection to see if injections reduce SCI-induced enhancement of paw 
withdrawal responses. AMG9810 application 1 month after SCI significantly 
reversed both heat hypersensitivity (12.99 ± 0.60 s) and mechanical 
hypersensitivity (11.70 ± 1.88 g) (Fig. 8A, B), while vehicle injection (n = 6) failed 
to reduce the hypersensitivity (Fig. 8A, B).	  For heat sensitivity (Fig. 8A) two-way 
ANOVA with repeated measures revealed significant effects of the test sequence 
(pretest, post-SCI, post-injection) (F2,17 = 11.37; P = 0.007) and drug treatment 
(F1,11 = 10.70; P = 0.008), with latencies for withdrawal to noxious heat significantly 
longer after injection of AMG9810 than vehicle (P = 0.0003; n = 6 animals in each 
group). For mechanical sensitivity (Fig. 8B) two-way ANOVA with repeated 
measures revealed significant effects of the test sequence (injury and recovery) 
(F2,17 = 6.98; P = 0.006) and drug treatment (F1,11 = 19.09; P = 0.001), with 
mechanical thresholds significantly greater after injection of AMG9810 than vehicle 
(P = 0.015; n = 6 animals in each group). These results indicate that ongoing 
activation of TRPV1 channels contributes substantially to chronic heat and 
mechanical hypersensitivity after SCI. 
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Figure 8. AMG9810, a specific TRPV1 channel blocker, ameliorates SCI-
induced mechanical and thermal hypersensitivity. A, summary data indicates 
that AMG9810 (30 mg/kg, i.p.), but not vehicle (saline), reversed established 
thermal hypersensitivity (decreased hindpaw withdrawal latency) induced by 
SCI 30 min after injections. B, summary data indicates that AMG9810 (30 
mg/kg, i.p.), but not vehicle (DMSO), reversed established mechanical 
hypersensitivity (decreased hindpaw withdrawal threshold) induced by SCI 
30 min after injections. *, comparing to postcontusion before AMG9810. #, 
comparing to postcontusion with vehicle. AMG, AMG9810. 	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5.2.2. Reversal of SCI-induced heat and mechanical hypersensitivity by 
knockdown of TRPV1. 
It has been demonstrated that knocking down TRPV1 channels is sufficient to 
reverse behavioral signs of pain induced by nerve injury and inflammation 
(Christoph et al., 2006; Christoph et al., 2007; Christoph et al., 2008). Thus, I used 
ODN targeted to mRNA of TRPV1 channels (Christoph et al., 2007) to further 
evaluate the role of TRPV1 channels in SCI-induced chronic pain. This ASO is 
reported to induce nearly complete degradation of TRPV1 mRNA, and can be 
taken up well in vivo by DRG neurons after intrathecal delivery (Christoph et al., 
2007).	  To confirm that expression of TRPV1 protein in L4/L5 DRG neurons was 
knocked down and to estimate the degree of knockdown, protein abundance was 
assessed by western blotting, and the degree of functional knockdown was 
assessed by electrophysiological recording of capsaicin-evoked currents. Western 
blot analysis showed that ASO treatment was effective in knocking down TRPV1 
protein expression in L4 and L5 DRG from animals treated for 5 days with ASO 
injections 6 weeks after contusive SCI (Fig. 9A, B). The intensity of the band 
representing TRPV1 was significantly decreased (by 63%) in samples taken from 
rats treated with ASO targeting TRPV1, as compared to samples taken from rats 
treated with a MMO (n = 6; P = 0.0058) (Fig. 9B). No significant difference was 
found in the intensity of the band representing TRPV4, another member of the 
TRPV family (Guler et al., 2002; Tominaga, 2007) when comparing DRG from the 
TRPV1 ASO group and MMO group (Fig. 9B). This suggests that the ASO 
treatment was specific to TRPV1. Finally, the ASO effect on TRPV1 was 
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Figure 9. Intrathecal delivery of antisense oligodeoxynucleotide targeting 
TRPV1 specifically knocked down TRPV1 in DRG. Representative band (A) 
and summary data (B) from western blots indicate that ASO, but not MMO, 
knocked down TRPV1 protein expression by about 63% in lumbar DRG. 
Furthermore, TRPV4 protein levels were almost the same between tissues 
dissociated from ASO and MMO treated SCI rats. Intensities of 
TRPV1/TRPV4 bands were normalized to that of β-actin.  C, Comparison of 
capsaicin-sensitive currents among adult DRG neurons dissociated from ASO 
and MMO pretreated SCI rats. 3 µM capsaicin-induced currents were 
significantly decreased in ASO group as compared to MMO group (36 hours 
after the last ODN injection). MMO, mismatch ODN; ASO, antisense ODN. 
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 confirmed functionally. Capsaicin-induced inward current measured at a holding 
potential of -60 mV in DRG neurons dissociated from the MMO group (240 pA/pF, 
n = 20 neurons) was similar to that recorded from the untreated SCI group (Fig. 
4B). However, capsaicin-induced inward current was significantly reduced in DRG 
neurons dissociated from ASO rats (137 pA/pF, n = 19 neurons; P = 0.0358) (Fig. 
9C). ). This 43% decrease brought the mean amplitude of capsaicin-evoked 
currents in ASO-treated SCI animals (Fig. 9C) close to the levels exhibited by 
neurons taken from naive (128 pA/pF) and sham-treated animals (124 pA/pF) 
(Fig. 4B). 
 
One month after SCI, the mechanical and heat thresholds for withdrawal of 
hindpaws in response to stimulation of the plantar surface with von Frey filaments 
or heat were measured and compared to the threshold measured in the same 
animal just before spinal injury (day -1). The thresholds for mechanical and heat 
stimulation were lowered to 46.91% and 62.37% of the control in the operated 
animals, respectively. Some of the SCI animals (n = 6) then received intrathecal 
administration of TRPV1 ASO molecules at the L4/L5 level twice daily for 3 days, 
and then once per day for 2 days. MMO treatment served as control in the 
remaining SCI animals (n = 5). The heat and mechanical thresholds were 
measured again ~15 hours after the last ODN injection (prior to harvesting the 
DRG). As shown in Figure 10A and B, the specific knockdown of TRPV1 
significantly attenuated SCI-induced mechanical (from 3.36 ± 0.55 to 14.03 ± 1.46 
g) and heat (from 7.15 ± 0.43 to 11.17 ± 0.75 s) hypersensitivity, whereas the 
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Figure 10. TRPV1 knocking down significantly decreases reflex sensitization 
after SCI. Hindlimb withdrawal responses to mechanical and radiant heat 
stimuli were tested with standard methods before SCI, after SCI, and after 
ODN injections (during the 4th and 5th d of a 5-d knockdown sequence). The 
last behavioral test was followed by harvesting of DRG and dissociation of 
neurons for cellular tests. Both thermal (A) and mechanical (B) sensitivity were 
increased 1 mo after spinal contusion. Subsequent intrathecal injection of 
ASO but not MMO, reversed at least part of the mechanical and thermal 
hypersensitivity. *, comparing to postcontusion before ASO. #, comparing to 
postcontusion with MMO. MMO, mismatch ODN; ASO, antisense ODN. 
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 responses did not change in the MMO group for both mechanical (from 5.99 ± 
1.85 to 5.87 ± 0.89 g, n = 6) and thermal (from 7.15 ± 0.52 to 7.38 ± 0.68 s, n = 6) 
tests. For heat sensitivity (Fig. 10A) two-way ANOVA with repeated measures 
revealed a significant effect of the test sequence (pretest, post-SCI, post-ODN) 
(F2,18 = 22.78; P < 0.0001) and ODN treatment (F1,9 = 11.03; P = 0.0090), with 
latencies for withdrawal to moderately noxious heat significantly longer after 
injection of ASO (n = 6) than MMO (n = 5; P = 0.0051). For mechanical sensitivity 
(Fig. 10B) two-way ANOVA with repeated measures revealed significant effects of 
the test sequence (injury and recovery) (F2,1 = 6.98; P = 0.006). A partitioned 
analysis on each factor using one-way ANOVAs and pairwise comparisons at 
each test revealed a significant effect of ODN treatment in the post-ODN test, with 
the threshold for withdrawal higher in ASO-treated than MMO-treated rats  (P = 
0.007). These results show that TRPV1 ASO treatment can effectively reverse 
chronic behavioral hypersensitivity to heat and mechanical stimuli after SCI. 
 
5.2.3. TRPV1 channel knockdown, but not acute block, decreases enhanced 
spontaneous activity in dissociated nociceptors after SCI 
We also measured the incidence of SA in DRG neurons dissociated from SCI 
rats treated with ODN. Unexpectedly, in the near absence of nearby cells 
(potential sources of TRPV1 ligands) SA incidence in ASO DRG neurons (6 out of 
19) was lower than that from MMO DRG neurons (15 out of 20) (P = 0.010, 
Fisher's exact test, Fig. 11A and B). The firing rate of the DRG neurons that did 
display SA was unchanged after previous ASO treatment compared to MMO 
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Figure 11. Knocking down TRPV1 channel in vivo decreases the excitability 
of dissociated nociceptors.  A, example of lack of SA in a small DRG neuron 
from an ASO-treated SCI animal (right trace). A similar neuron from an MMO-
treated animal displayed typical SCI-induced SA (left trace). This and other 
prolonged recordings were digitized at a low sampling rate (2 KHz), so the 
action potentials are clipped.  B, summary data indicates incidence of SA in 
DRG neurons dissociated from MMO or ASO pretreated SCI animals. C, Lack 
of effect of TRPV1 ASO treatment on SA firing rate in the neurons (n = 6) that 
still fired spontaneously after the treatment. ASO, antisense ODN; MMO, 
mismatch ODN.  
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 treatment (Fig. 11C). Tests performed after SA measurement showed that all of 
these cells were capsaicin-sensitive.  
I then tested whether intrinsic TRPV1 channel activity contributes to SCI-
induced SA in dissociated DRG neurons after SCI via endogenous ligands binding 
to the capsaicin-binding site (Jara-Oseguera et al., 2008) by testing the effects of 
AMG9810 on SA in vitro. DRG neurons were dissociated from rats 1 month post-
SCI. Only neurons exhibiting SA were tested. The threshold for SA generation was 
determined by applying a series of descending hyperpolarizing pulses (5 s each). 
Multiple ion channels are probably involved in intrinsic SA generation, and 
blocking one might not be enough to hyperpolarize cells below action potential 
threshold and thus reveal the involvement of TRPV1 channels in SA generation. 
Thus, I hyperpolarized neurons displaying SA to a potential just above SA 
threshold and recorded stable SA. Cells were then exposed to 10 µM AMG9810 
for another 15 s followed by washout. AMG9810 failed to decrease SA in this 
controlled recording condition (Fig. 12A), although it blocked currents evoked by 
application of 1 µM capsaicin (Fig. 12B). The failure of AMG9810 to reduce SA in 
vitro after SCI suggests that the SA under this condition is not promoted by 
ongoing activation of TRPV1 via the capsaicin-binding site on the channel.  
 
5.3. Conclusions 
5.3.1. TRPV1 channels, especially those expressed in primary sensory 
neurons, play an important role in SCI-induced chronic pain 
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In these studies, I used both pharmacological and molecular methods to 
provide strong evidence supporting my hypothesis that activation of TRPV1 
channels contributes significantly to SCI-induced chronic pain. First of all, SCI rats 
developed both thermal and mechanical hyperreflexia, since the thresholds were 
decreased to both radiant heat and von Frey filament stimuli 1 month after SCI. 
This behaviorally expressed hypersensitivity after SCI was largely reversed by 
systemic delivery of AMG9810, which suggests that TRPV1 channels play an 
important role in SCI-induced chronic pain. In addition to their high expression in 
primary nociceptors, TRPV1 channels have also been reported in brain tissue, and 
in dorsal horn neurons (Caterina et al., 1997; Mezey et al., 2000; Cui et al., 2006; 
Kim et al., 2012). Because AMG9810 penetrates the blood brain barrier, 
AMG9810-induced effects may result not only from actions on its target in primary 
nociceptors, but also on TRPV1 channels in the CNS. After intrathecal injection of 
antisense ODN targeting TRPV1, both capsaicin-induced currents in DRG neurons 
and TRPV1 band intensity in DRG were significantly decreased in the ASO group 
as compared to the MMO group. A stronger ASO-induced knockdown compared 
to the decrease in capsaicin-induced currents may be due to the fact that the 
capsaicin currents were measured ~36 hours after the last ODN injection, a time 
when significant recovery of TRPV1 protein expression should have occurred 
compared to when samples were taken for western blot assays (~18 hours after 
the last ODN injection). Furthermore, ASO targeting TRPV1 failed to alter the band 
intensity of TRPV4. These data strongly suggest that intrathecal injection of 
antisense ODN targeting TRPV1 specifically knocked down TRPV1 channels in 
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DRG, and possibly the dorsal horn. The extent to which TRPV1 channels are 
expressed in the spinal cord is controversial (Caterina et al., 1997; Cui et al., 2006; 
Cavanaugh et al., 2011; Kim et al., 2012; Zhang et al., 2012). TRPV1 knockdown 
was accompanied by decreased heat and mechanical hypersensitivity. Given that 
TRPV1 channel expression is highest by far in primary sensory neurons 
(Tominaga, 2007), and its expression in dorsal horn neurons may be very low, it 
seems likely that much of the effects induced by AMG9810 and by antisense ODN 
treatment result from reducing the activity of TRPV1 channels expressed in 
primary sensory neurons.   
 
5.3.2. TRPV1 channel activity in vivo but not in vitro is important for 
maintaining intrinsic SA of nociceptors after SCI. 
It was surprising to find that ASO significantly decreased SA incidence in 
dissociated nociceptors. Because of the very low cell density in this in vitro 
preparation, it is unlikely that this effect results from disrupted in vitro basal activity 
maintained by ongoing exposure to endogenous TRPV1 activators, such as lipid 
products, released by nearby cells. During current clamp recording, DRG neurons 
were constantly perfused by external solution, which would wash away any 
secreted activators. Also, AMG9810 failed to block or reduce the firing rate in 
those DRG neurons that did display SA, whereas the same concentration of 
AMG9810 was enough to block 1 µM capsaicin-induced currents. These 
observations indicate that SA in vitro is not maintained by endogenous ligands 
binding to the common AMG9810- and capsaicin-binding site on TRPV1. An 
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alternative hypothesis that should be tested in the future is that knockdown of 
TRPV1 expression may impair a positive-feedback loop in vivo in which 
endogenous activators of TRPV1 (in the dorsal horn and/or the DRG) promote an 
intrinsic hyperexcitable-spontaneously active state in nociceptors that can maintain 
SA in a nociceptor for at least 1 day after dissociation (Bedi et al., 2010; Walters, 
2012). For example, evidence exists for neuron-glia interactions where extensive 
sensory excitation activates glial cells, which in turn cause plasticity of DRG 
neurons (Miller et al., 2009; Xie et al., 2009).  
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Figure 12. Lack of effect of AMG9810 on SA firing rates.	  A, summary data 
indicates AMG9810 failed to alter SA rate in a controlled condition where 
DRG neurons displaying SA were hyperpolarized to just above SA threshold. 
After current-clamp recording, cells in A and B were switched to voltage-
clamp model, capsaicin was then applied to confirm that they had TRPV1 
channels. B, 10 µM AMG9810 effectively blocked capsaicin (1µM)-induced 
current (upper trace) in capsaicin-sensitive neurons (lower trace). AMG, 
AMG9810; Caps, capsaicin. 	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CHAPTER 6: TRPV1 channels are involved in SCI-induced 
spontaneous activity in nociceptors 
 
6.1. Introduction 
SA in DRG neurons has been implicated as a potentially important contributor to 
chronic pain in several different models, including SCI. SA has been investigated 
most extensively in large DRG neurons after peripheral nerve injury or 
inflammation (Wall and Devor, 1983; Xie et al., 2005). In large DRG neurons SA 
has been shown to depend on subthreshold spontaneous oscillations of 
membrane potential, the amplitude of which increases with depolarization (Devor, 
2009). Peripherally generated SA also occurs in peripheral inflammation and injury 
models in nociceptive C-fiber neurons (Wu et al., 2001; Djouhri et al., 2006). 
Contusive SCI at T10 causes an increase in the incidence of peripherally 
generated SA in small diameter nociceptors recorded from a forelimb nerve 
(Carlton et al., 2009), and a dramatic increase in SA recorded from lumbar dorsal 
roots and dissociated small DRG neurons that is probably generated in the 
nociceptor soma (Bedi et al., 2010). The SA in dissociated neurons was 
associated with depolarization of the cell body (Bedi et al., 2010), as had been 
described in large DRG neurons exhibiting SA after nerve injury (Amir et al., 1999). 
Also, some DRG neurons with SA exhibit more negative thresholds for triggering 
action potentials (Study and Kral, 1996; Bedi et al., 2010). Under these conditions, 
any small inward currents, including currents through TRPV1 channels, should 
promote action potential generation. TRPV1 channels can be activated by various  
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Figure 13. Depolarization induces repetitive firing (RF) in previous silent DRG 
neurons. A, depolarization increased subthreshold oscillations (SOs, red 
arrows) and induced repetitive firing (RF) in majority of DRG neurons (left 
trace), while a few of cells showed accommodation (Ac, right trace). B, 
depolarization required to reach threshold was similar in cells displaying 
repetitive firing and accommodation. C, sustained, low-frequency firing 
occurred in > 90% of capsaicin-sensitive nociceptors. In contrast, capsaicin-
insensitive DRG neurons often accommodated during prolonged 
depolarization. In current clamp mode, a series of depolarizing currents (from 
0 to 100 pA for 5 s with 5 pA increments) were injected into small silent DRG 
neurons dissociated from naïve rats. RMP, resting membrane potential. 
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lipid products (see Chapter 1), and many of these lipid products are elevated in the 
spinal cord after SCI (Liu and Xu, 2010). Also, I have shown that SCI enhances 
TRPV1 channel function. Thus, I tested the hypothesis that activation of TRPV1 
channels can contribute to the chronic SA observed in nociceptors after SCI. 
 
6.2. Results 
6.2.1. Depolarization induces repetitive firing in most nociceptors 
Since DRG neurons displaying SA are usually depolarized as compared to 
silent neurons, and activation of TRPV1 channels depolarizes DRG neurons, I 
tested whether membrane depolarization enhances repetitive firing in silent DRG 
neurons. DRG neurons were dissociated from naïve rats. In current clamp mode a 
series of currents (from 0 to 100 pA for 5 s with 5 pA increments at 10 s intervals) 
was injected into silent DRG neurons. A majority of the tested DRG neurons 
showed increased amplitudes of subthreshold spontaneous oscillations during 
depolarizing pulses (Fig. 13A). When membrane potentials were depolarized (to 
about -43 mV in this example), repetitive firing occurred in most of the neurons, 
and continued without accommodation for as long as the injected currents were 
applied (Fig. 13A and C). In contrast, a small proportion of tested DRG neurons 
failed to increase the amplitude or frequency of subthreshold spontaneous 
oscillations when currents injected (Fig. 13B). These cells generated only one or 
two action potentials at the beginning of the pulse when membrane potential was 
depolarized (-46 mV in the example in Fig. 13B); however, the spiking was not 
sustained even though currents equal to twice the rheobase were injected (Fig 
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13B and C). Interestingly, cells displaying repetitive firing during depolarizing 
stimulation usually responded to capsaicin under voltage-clamp (holding the 
neuron at -60 mV), while 2 out of the 3 DRG neurons showing accommodation 
failed to exhibit any currents in response to capsaicin application. 
 
6.2.2. Spontaneous activity requires extracellular Ca2+ 
It has been demonstrated that SO and SA in large Aβ DRG neurons are 
blocked by the voltage-gated Na+ channel blocker, TTX, but not voltage-gated 
Ca2+ channel blockers (Matzner and Devor, 1994; Amir et al., 1999). However, 
nothing is known about the ionic dependence of subthreshold spontaneous 
oscillations and SA in C-fiber neurons. I tested whether the same ionic 
mechanisms reported to be important for SA in large DRG neurons also underlie 
SA generation in small DRG neurons. 18-24 hours after dissociation from SCI rats, 
L4/L5 DRG neurons displaying SA were recorded under whole-cell current clamp. 
SA was first recorded for 15 s in normal external solution. External solution 
containing TTX (300 nM) or lacking Ca2+ (with Ca2+ replaced by Mg2+ in the 
external solution) was applied for another 30 s followed by washout. In contrast to 
what has been reported in large DRG neurons (Amir et al., 1999), 300 nM TTX 
failed to inhibit SA in small DRG neurons (Fig. 14). However, when these cells 
were exposed to Ca2+-free external solution, SA firing rate was greatly decreased 
(from 1.84 ± 0.59 to 0.14 ± 0.09, P = 0.02, paired t-test, Fig 15A and B) while 
membrane potential was not significantly changed (Fig. 15C). These results 
indicate that extracellular Ca2+ is important for SA generation. 
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Figure 14. TTX fails to inhibit SA in small DRG neurons. A, Representative 
traces showing that bath application of TTX (300 nM) had no effect on SA in 
a DRG neuron dissociated from a SCI rat. B, Summary data showed that 
TTX failed to inhibit SA. TTX, tetrodotoxin. 	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Figure 15. Removing Ca2+ from extracellular solution decreases SA.  A, 
Representative recordings showing that Ca2+-free solution reduced the 
incidence of spontaneous firing in a neuron examined 1 month after SCI. B, 
summary data showing that removing extracellular Ca2+ significantly 
decreased the firing rate (comparing to its baseline) of DRG neurons (paired 
t-test). C, summary data showing that removal of extracellular Ca2+ did not 
change resting membrane potentials. 	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6.2.3. Low concentrations of capsaicin induce repetitive firing in nociceptors 
When TRPV1 channels in DRG neurons are activated, extracellular Ca2+ and 
Na+ diffuse through the channels into the cell, causing depolarization. Because 
depolarization and extracellular Ca2+ are required for generation of both SA and 
non-accommodating repetitive firing in small DRG neurons, I tested whether 
limited activation of TRPV1 is sufficient to induce repetitive firing in nociceptors. 
Silent DRG neurons dissociated from naïve rats were recorded under current 
clamp at the resting membrane potential for 15 s. Cells were then exposed to 10 
nM or 50 nM capsaicin for 30 s followed by washout. Most of the DRG neurons 
were gradually depolarized during capsaicin application (Fig. 16A). The 
depolarizing response was concentration dependent; 10 nM and 50 nM capsaicin 
depolarized membrane potential by 3.22 ± 1.05 and 6.53 ± 1.22 mV, respectively 
(Fig. 16B). Some of the cells generated repetitive firing during the capsaicin-
induced depolarization (Fig. 16A), with 6 out of 10 silent DRG neurons showing 
repetitive firing during 50 nM capsaicin application, and 3 of 8 neurons showing 
repetitive firing during 10 nM capsaicin application (Fig. 16C). All these cells 
became silent when membrane potential recovered after washout of the capsaicin. 
The recording configuration was then switched to voltage-clamp mode, holding at -
60 mV, and sensitivity to a saturating concentration of capsaicin (3 µM) was 
tested. Capsaicin-insensitive cells were excluded from the analysis. These results 
show that low concentrations of capsaicin can induce repetitive firing in 
nociceptors from naive animals. 
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Figure 16.	  Low concentrations of capsaicin depolarize nociceptors and 
produce repetitive firing in previously silent neurons. A, representative traces 
showing that addition of capsaicin (10 nM) induces repetitive firing in a 
previously silent neuron.  Low concentrations of capsaicin induced membrane 
depolarization (B) and continuous firing (C) in a concentration dependent 
manner.  	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6.2.4. Prolonged application of low concentrations of capsaicin induces 
repetitive firing without accommodation 
It been suggested that endogenous TRPV1 activators may accumulate and 
continuously activate TRPV1 channels under various pathological conditions (Shin 
et al., 2002; Starowicz et al., 2007), which could produce sustained repetitive firing 
of primary nociceptors. It is well known that relatively high concentrations of 
capsaicin induce strong desensitization of TRPV1 channels (Cholewinski et al., 
1993; Koplas et al., 1997). Endogenous activators of TRPV1 probably exist in very 
low concentration in vivo (Huang et al., 2002). I therefore examined whether 
prolonged application of a very low concentration of capsaicin can induce non-
accommodating repetitive firing in silent nociceptors, and, if so, whether this effect 
is enhanced by SCI. DRG neurons were dissociated from rats 1-2 months post-
SCI, as well as from age-matched naïve animals. Silent DRG neurons were 
recorded using the perforated patch current-clamp method at the neuron's resting 
membrane potential for 30 s. Each neuron was then exposed to 10 nM capsaicin 
for 10 min or longer followed by washout. Similar to what was observed with the 
30-s capsaicin applications, the much longer application of 10 nM capsaicin 
gradually depolarized membrane potential and triggered repetitive firing. The firing 
rate was low initially, but gradually increased with further membrane depolarization 
and become stable within 2 min. Sustained depolarization during the capsaicin 
exposure was always accompanied by an increase in amplitude of subthreshold 
spontaneous oscillations of membrane potential. Importantly, both the firing rate 
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and depolarized membrane potential showed no apparent recovery for as long as 
the cells were exposed to capsaicin (Fig 17).  
 
The increases in TRPV1 expression and function I demonstrated in DRG 
neurons after SCI predicted that SCI should also increase the responsiveness of 
dissociated DRG neurons to very low concentrations of capsaicin. Therefore, I 
compared the degree of membrane depolarization and the percentage of silent 
cells that fired repetitively during 10-min exposure to 10 nM capsaicin between 
SCI and naïve groups. Silent DRG neurons (n = 16) from SCI animals showed 
significantly greater depolarization of resting membrane potential during this 
capsaicin exposure than neurons (n = 16) dissociated from naive animals (Fig. 
18A and B; P < 0.001, paired t-test). Correspondingly, 10 nM capsaicin induced 
repetitive firing in 81.25% (13/16) silent neurons dissociated from SCI rats, 
whereas only 5 out of 14 neurons from naive rats showed repetitive firing during 
10 nM capsaicin application (Fig. 18C, P = 0.024, Fisher's exact test). After 
switching to voltage-clamp mode, currents evoked by 3 µM capsaicin were 
recorded at -60 mV. Capsaicin-insensitive cells were excluded from analysis. 
These results show that SCI increases the likelihood that very low concentrations 
of a TRPV1 activator will cause persistent, non-accommodating firing of previously 
silent nociceptors. 
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Figure 17. Prolonged application of low concentrations of capsaicin 
promotes SA without accommodation in subsequently dissociated 
nociceptors. Perforated patch recording showing non-desensitizing excitation 
of a dissociated DRG neuron by 11 min exposure to 10 nM capsaicin.  
Inserted traces from the same record show the increased amplitude of 
spontaneous membrane oscillations during the capsaicin-evoked 
depolarization. Action potentials and afterhyperpolarizations are clipped in 
the insert.  Red arrows indicate subthreshold oscillations (SOs).  
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Figure 18. SCI enhances the sensitivity of DRG neurons upon limited TRPV1 
activation. A and B, SCI increased capsaicin-induced depolarization in DRG 
neurons. C, increased incidence of firing evoked by prolonged application of 10 
nM capsaicin in neurons dissociated from SCI animals. Caps, capsaicin. 	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6.3. Conclusions 
6.3.1. Membrane depolarization and extracellular Ca2+ are important for 
generation of SA and repetitive firing in small DRG neurons 
Large diameter DRG neurons fire repetitively upon depolarization, and the 
repetitive firing is sensitive to TTX and insensitive to Ca2+ channel blockers (Amir 
et al., 1999). Nociceptors are usually small and sometimes medium-sized DRG 
neurons, which express many differences in molecular and electrophysiological 
properties as compared to large DRG neurons. For example, small nociceptive 
DRG preferentially express TTX-resistant Na+ channels and TRPV1 channels 
(Akopian et al., 1996; Caterina et al., 1997). Thus, the molecular mechanisms 
underlying the generation of SA and repetitive firing may be different in 
nociceptors. Similar to what was described in large DRG neurons (Amir et al., 
1999), depolarizing current injection induced non-accommodating repetitive firing 
in most capsaicin-sensitive DRG neurons. The few neurons that showed 
accommodation (little or no repetitive firing) were usually insensitive to capsaicin. 
These studies indicate that a function of TRPV1-expressing nociceptors is to fire 
repetitively upon modest depolarization. Voltage-gated Na+ channels are critical 
for action potential generation. In this study, 300 nM TTX had no effect on SA, 
suggesting that TTX-resistant Na+ channels (Nav1.8 and/or Nav1.9), but not TTX-
sensitive Na+ channels are required for SA generation in dissociated nociceptors. 
In addition, I found that extracellular Ca2+ is important for SA generation. In this 
study, I simply substituted Ca2+ with Mg2+ in the extracellular solution, so there was 
still probably a physiologically significant amount of Ca2+ in the recording chamber 
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while the cells exposed to the nominally "Ca2+-free" solution. Nevertheless, this 
result indicates that a sufficient amount of extracellular Ca2+ is also required for SA 
generation. 
 
6.3.2. Limited activation of TRPV1 channels in DRG neurons is sufficient to 
generate repetitive firing without accommodation 
Consistent with a requirement for depolarization and extracellular Ca2+ for SA 
generation, I found that very low concentrations of capsaicin induced membrane 
depolarization and repetitive firing similar to SA. I chose a low concentration of 
capsaicin because: 1) the endogenous activators of TRPV1 are probably very low 
in physiological (and pathological) conditions in vivo (Huang et al., 2002); 2) higher 
concentrations of capsaicin cause larger amounts of Ca2+ and Na+ to enter 
neurons, strongly depolarizing the neurons and inactivating voltage-gated Na+ 
channels, thus inhibiting the excitability of DRG neurons, as well as desensitizing 
the TRPV1 channels (Cholewinski et al., 1993; Koplas et al., 1997; Wu and Pan, 
2007). In my studies, low concentrations of capsaicin induced modest membrane 
depolarization, and caused repetitive firing in some of the cells. An important 
feature of TRPV1 channel is desensitization upon prolonged or repeated exposure 
of activators (Cholewinski et al., 1993; Koplas et al., 1997; Touska et al.), which 
attenuates capsaicin-induced effects. However, my study indicated that little or no 
desensitization occurred with prolonged application (10 min) of 10 nM capsaicin, 
which produced constant depolarization of the cells before washout in perforated 
patch recordings. This experimental condition may better reflect the actions of 
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endogenous activators of TRPV1 channels in vivo during chronic pain conditions 
than the more common experimental conditions where high, desensitizing 
concentrations of capsaicin are applied.  
 
6.3.3. SCI enhances the responsiveness of DRG neurons to limited activation 
of TRPV1 channels 
As compared to DRG neurons dissociated from naïve rats, SCI enhanced not 
only the currents evoked by a saturating concentration of capsaicin, but also more 
physiological responses (depolarization and repetitive firing) to very low 
concentrations of capsaicin. This confirmed predictions based on the observed 
increases in TRPV1 expression and function after SCI. In vivo, SCI may cause an 
elevation of endogenous TRPV1 channel activators in the DRG and spinal cord, 
where they might produce the same effects as I found with prolonged application 
of a very low concentration of capsaicin, helping to depolarize and drive SA in 
nociceptors. Thus, after SCI, continuing activation of TRPV1 channels by low 
concentrations of endogenous ligands in vivo might contribute to the maintenance 
of nociceptor SA, and thereby to SCI-induced chronic pain. 
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CHAPTER 7: Discussion 
 
The goal of the studies described in this dissertation was to test two 
hypotheses: 1) that SCI increases the expression and function of TRPV1 in 
primary nociceptors, contributing to intrinsic SA and hyperexcitability in these 
neurons, and 2) that behaviorally expressed hypersensitivity to heat and 
mechanical stimuli following SCI can be reduced by attenuating TRPV1 activity. As 
discussed below, these hypotheses were supported by my findings that SCI leads 
to upregulation of TRPV1 channels in DRG neurons, and enhances the sensitivity 
of isolated nociceptor somata to high and low concentrations of a selective 
activator of TRPV1, capsaicin. Unexpected support for these hypotheses also 
came from my discovery that very low concentrations of capsaicin can promote SA 
without producing obvious desensitization, and that this effect is enhanced by SCI. 
Most important, interventions that reduced TRPV1 function provided evidence that 
TRPV1 channels play an important role in maintaining chronic behavioral 
hypersensitivity after SCI.  
 
7.1. SCI enhances capsaicin responses in small DRG neurons by 
upregulating TRPV1 channels. 
My first hypothesis is strongly supported by the findings that upregulation of 
TRPV1 after SCI was associated with increased responses to a saturating 
concentration of capsaicin, as measured by voltage clamp (Fig. 4) and Ca2+ 
imaging (Fig. 6). These findings suggest that SCI produces a persistent increase 
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in the number of functional TRPV1 channels in the plasma membrane of primary 
nociceptors. I observed increases of capsaicin-induced responses in the cell 
bodies of DRG neurons 1 month, but not 3 days, after contusion, suggesting a 
delayed increase in TRPV1 function after SCI. However, TRPV1 upregulation in 
the spinal cord (L6/S1) was reported to be detectable immunohistochemically as 
early as 3 days after T9 transection (Zhou et al., 2002). This difference might 
reflect earlier increases of TRPV1 protein after SCI in central terminals of DRG 
neurons than in cell bodies, or differences in the type of spinal injury (transection 
versus contusion) or the TRPV1 measure (immunohistochemistry versus capsaicin 
sensitivity). A delayed effect on capsaicin sensitivity in DRG neuron somata after 
SCI might reflect a requirement for transport of SCI-induced factors from central 
terminals to the somata of DRG neurons (Walters, 2012).  
 
The TRPV1-dependent effects I observed are unlikely to be direct results of 
axonal injury produced in the tested DRG neurons by SCI. Most C and Aδ fibers 
only project 1-2 segments from their segment of entry (Chung et al., 1979). In this 
study, DRG neurons were taken from L4/L5, which is far below the contusion site, 
so they were unlikely to be axotomized or directly damaged by the contusion (Bedi 
et al., 2010). However, descending and ascending fibers passing through the 
injured level are likely to be directly affected by SCI. Destruction or injury to these 
fibers could remove inhibitory and/or excitatory influences on dorsal horn neurons 
(and glia) that might in turn affect central terminals of primary afferents after SCI 
(Hubscher et al., 2008; Densmore et al., 2012; Walters, 2012).  
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A shift toward larger DRG neurons in TRPV1 channel distribution has been 
reported in nerve injury and cancer chronic pain models, although this effect might 
be triggered by axotomy (Ma et al., 2005; Shinoda et al., 2008). On the other 
hand, peripheral inflammation increases the proportion of TRPV1-positive cells in 
small and medium-sized DRG neurons (Amaya et al., 2003). Although I found that 
the fraction small DRG neurons responding to capsaicin was unchanged after SCI, 
I cannot exclude the possibility that TRPV1 also increases in larger neurons, 
because large DRG neurons were not sampled in my experiments. Indeed, an 
increase in soma diameter in TRPV1-positive DRG neurons (L4/L5) has been 
reported after high thoracic (T3), but not low thoracic (T10) spinal cord transaction 
(Ramer et al., 2012). 
 
TRPV1 channel function might be enhanced in nociceptors following SCI due 
to increased expression of the channels. Increases in TRPV1 protein expression in 
the dorsal horn of the spinal cord have been found after SCI, as detected by 
immunohistochemistry and RT-PCR, (Zhou et al., 2002; DomBourian et al., 2006). 
Similar to a recent study in which high thoracic (T3) transection increased staining 
intensity of TRPV1 in L4/L5 DRG (Ramer et al., 2012), I found that TRPV1 
expression was increased in L4/L5 DRG 1 month after T10 contusion. 
Upregulation of TRPV1 in primary afferent neurons has been described in various 
inflammatory situations and in undamaged neurons (likely exposed to 
inflammatory signals) in neuropathic pain models (Hudson et al., 2001; Fukuoka et 
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al., 2002; Ji et al., 2002; Breese et al., 2005; Kanai et al., 2005). A greater role of 
inflammation than axon injury in the upregulation of TRPV1 in L4/L5 nociceptors is 
suggested by the distance of these DRG from the T10 contusion site in my 
studies.  Few primary nociceptor axons project that far, so few would be 
axotomized. In addition, widespread inflammation occurs in the spinal cord after 
SCI (Alexander and Popovich, 2009; Dulin et al., 2013 ) (affecting central 
processes of nociceptors), and inflammatory cells can inflitrate into DRG several 
segments away from an SCI site (McKay and McLachlan, 2004).  
 
TRPV1 expression is regulated by NGF. In rats made hyperalgesic by 
peripheral inflammation, NGF is elevated in the inflamed skin (Woolf et al., 1994). 
This peripherally produced NGF is believed to be involved in TRPV1 upregulation 
in the DRG by activating the p38 signaling pathway (Ji et al., 2002). It is not known 
whether SCI increases NGF in DRG, but NGF levels are elevated in the spinal 
cord after SCI (Bakhit et al., 1991; Murakami et al., 2002; Brown et al., 2004). 
Elevated NGF may be communicated to primary sensory neurons via their central 
terminals, and this signaling might participate in the upregulation of TRPV1 
channels in DRG neurons, thus increasing nociceptor excitability and contributing 
to the development of abnormal somatosensory behaviors after SCI (Gwak et al., 
2003).  
 
7.2. TRPV1 activation is important for nociceptor SA after SCI 
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We have previously demonstrated that SCI promotes SA in the cell bodies of 
small DRG neurons that usually respond to capsaicin (Bedi et al., 2010). Thus an 
important question is whether upregulated TRPV1 channels can enhance SA 
generation in nociceptors. Although the endogenous agonists of TRPV1 are 
uncertain, various lipid products are able to activate TRPV1 ion channels (Bang et 
al., 2010). For example, the endogenous cannabinoid receptor agonist 
anandamide and 12-lipoxygenase metabolites of arachidonic acid (AA) activate 
both native and cloned TRPV1 channels (Zygmunt et al., 1999; Hwang et al., 2000; 
Watanabe et al., 2003). Opening TRPV1 channels by PKC activation was also 
reported (Premkumar and Ahern, 2000). TRPV1 channel currents induced by 
endogenous activators may be very small or only detectable in a small proportion 
of DRG neurons (Shin et al., 2002). However, currents produced by endogenous 
activators may be enhanced after SCI, which could increase intrinsic SA and 
hyperexcitability of nociceptors since: 1) SCI induces a large accumulation of lipid 
products (Liu and Xu, 2010); 2) I have shown that the responsiveness of TRPV1 
channels is enhanced following SCI; 3) and nociceptors with SA are depolarized 
and exhibit reduced thresholds for the triggering of action potentials (Study and 
Kral, 1996; Bedi et al., 2010). This possibility is strongly suggested by my finding 
of sustained repetitive firing in response to prolonged application of a very low 
concentration of capsaicin to dissociated DRG neurons. Many endogenous 
activators act through the capsaicin-binding site of TRPV1 (Sutton et al., 2005; 
Jara-Oseguera et al., 2008; Wen et al., 2012). Thus, I mimicked ongoing actions of 
this general type of activator by prolonged application of capsaicin at a dose (10 
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nM), which is far lower than the EC50 values reported for dissociated DRG neurons 
in rats (200-500 nM) (Wood et al., 1988; McLatchie and Bevan, 2001). 
Remarkably, the low dose of capsaicin caused prolonged firing that showed no 
desensitization or accommodation for as long as the drug was present (> 10 min). 
Importantly, significantly more nociceptors dissociated from SCI animals showed 
repetitive firing under this condition compared to neurons dissociated from naïve 
rats. This suggests that upregulation of TRPV1 channels after SCI may enhance 
the ability of endogenous TRPV1 activators to promote SA generation in 
nociceptors in vivo.  
 
Capsaicin-induced depolarization was always associated with increased 
amplitude of spontaneous subthreshold oscillations of membrane potential (Fig. 
17), which are thought to underlie SA in larger DRG neurons (Amir et al., 1999). 
Thus, it is interesting to know whether enhanced TRPV1 channel function 
participates in SA generation in small DRG neurons. As compared to mismatch 
ODN treatment, DRG neurons dissociated from TRPV1 antisense ODN-treated 
rats showed decreased SA incidence. Although TRPV1 channel activity is likely to 
be important for nociceptor sensitization after SCI in vivo, AMG9810 failed to 
decrease SA in dissociated DRG neurons, which suggests that intracellular 
activators of TRPV1 are not involved in the maintenance of nociceptor SA after 
isolation of the neurons. Nonetheless, SCI-induced intrinsic SA may be promoted 
in vivo by increased responsiveness to extracellular TRPV1 activators that may be 
released chronically after SCI. An additional possibility is that elevated activity of 
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DRG neurons after injury helps to sustain astrogliosis and microgliosis (Xie et al., 
2009). Activated glial cells release cytokines, growth factors and other factors that 
enhance excitability of primary sensory neurons (Milligan and Watkins, 2009; Gao 
and Ji, 2010; Parpura and Zorec, 2010; Wang et al., 2012), which could produce a 
positive feedback loop, potentially contributing to the initiation and maintenance of 
nociceptor hyperexcitability (Miller et al., 2009; Walters, 2012). Breaking the 
positive feedback loop by knocking down TRPV1 might reduce or terminate 
intrinsic hyperexcitability in DRG neurons after SCI.  
 
7.3. TRPV1 activation is important for behavioral hypersensitivity after SCI 
The mechanisms just discussed suggest that TRPV1 activation may contribute 
to pain-related behavior, and these considerations led to my second hypothesis -- 
that reducing TRPV1 activity may reduce pain-related behavior after SCI. This 
hypothesis received strong support from my demonstration that behavioral 
hypersensitivity expressed by hindlimb withdrawal responses to heat and 
mechanical test stimuli after SCI was reversed by two interventions that reduce 
TRPV1 activity: acutely by delivery of the TRPV1 antagonist, AMG9810, and for 
longer periods by selective antisense knockdown of TRPV1 channels in lumbar 
DRG and spinal cord. 
 
The contribution of TRPV1 channels to peripherally generated neuropathic pain 
has been controversial (Caterina et al., 2000; Pomonis et al., 2003; Maione et al., 
2006). As heat-sensitive receptors, TRPV1 channels are expected to be important 
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for mediating heat hyperalgesia produced by inflammation or nerve injury. This 
expectation has been supported by the finding that peripheral delivery of a TRPV1 
antagonist, iodoresiniferatoxin, attenuates noxious heat (45°C)-induced excitation 
of spinal wide dynamic range (WDR) neurons in vivo in anaesthetized rats after 
carrageenan-induced inflammation or L5/6 spinal nerve ligation (Jhaveri et al., 
2005). On the other hand, behaviorally expressed thermal hypersensitivity still 
developed in TRPV1 knockout mice after partial nerve injury (Caterina et al., 
2000). Likewise, the involvement of TRPV1 channels in mechanical 
hypersensitivity is unclear. It has been reported that TRPV1 knockout does not 
prevent the development of behaviorally expressed mechanical hypersensitivity 
after nerve ligation (Caterina et al., 2000; Christoph et al., 2008). Furthermore, 
peripheral delivery of iodoresiniferatoxin failed to attenuate responses of WDR 
neurons to mechanical stimuli in anaesthetized rats after spinal nerve ligation 
(Jhaveri et al., 2005). Moreover, the expression level of TRPV1 channel is 
reported to be downregulated in nociceptors in at least one peripheral nerve injury 
model (Michael and Priestley, 1999). It should be noted, however, that the 
downregulation only occurs in axotomized DRG neurons; peripheral nerve injury 
increases TRPV1 expression in undamaged DRG neurons (Hudson et al., 2001), 
including previously TRPV1-negative A-fibers (Rashid et al., 2003). Also, 
peripheral inflammation enhances TRPV1 expression in small and medium-sized 
DRG neurons (Ji et al., 2002; Breese et al., 2005). Therefore, it is widely accepted 
that the TRPV1 channel is important for behaviorally expressed hypersensitivity in 
various pathologic situations. Indeed, selective TRPV1 antagonists have been 
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reported to attenuate both thermal and mechanical hypersensitivity in several 
neuropathic pain models (Pomonis et al., 2003; Honore et al., 2005; Kanai et al., 
2005; Drizin et al., 2006). Consistent with these pharmacological studies, knocking 
down TRPV1 in transgenic mice expressing shRNA against TRPV1 attenuated not 
only the development of thermal hyperlgesia, but also mechanical allodynia after 
spinal nerve ligation (Christoph et al., 2008). 
 
Although TRPV1 channels are expressed most abundantly in primary afferent 
neurons (Caterina et al., 1997; Tominaga, 2007) they are also reported to be 
present in spinal dorsal horn neurons and to contribute at that locus to the 
maintenance of pain (Cui et al., 2006; Kim et al., 2012). A recent study described 
TRPV1 channels located in spinal cord GABAergic interneurons, and provided 
evidence that these spinal TRPV1-expressing neurons are important for 
intrathecal capsaicin-induced mechanical hypersensitivity by showing reduction of 
hypersensitivity in TRPV1-/- mice and in wild-type mice in which TRPV1 
expressing neurons were desensitized by intrathecal spinal injection but not 
systemic injection of resiniferatoxin (Kim et al., 2012), an ultrapotent TRPV1 
agonist (Szallasi and Blumberg, 1999). However, this study does not exclude the 
involvement of TRPV1-expressing primary afferent neurons in mechanical 
hypersensitivity. For example, selectively silencing TRPV1-expressing axons in 
the sciatic nerve by introducing QX-314 (a membrane-impermeable Na+ channel 
blocker) into neurons via opening of TRPV1 channels abolished inflammation-
induced thermal and mechanical hyperalgesia, but not mechanical allodynia 
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(Brenneis et al., 2013). This suggests that TRPV1-expressing neurons may be 
more important for responses to stronger mechanical stimuli than those typically 
used in mechanical allodynia studies (Brenneis et al., 2013). Pharmacological 
evidence also indicates that in addition to its role in mediating thermal 
hypersensitivity, TRPV1 channels expressed in primary afferent neurons also play 
an important role in mechanical allodynia  (Cui et al., 2006). Systemic application 
of A-795614, a peripherally restricted TRPV1 antagonist, significantly reduced 
mechanical allodynia in a peripheral inflammatory pain model, although less 
effective than A-784168, a TRPV1 antagonist with good blood-brain barrier 
penetration.  Both antagonists showed similar potency on thermal hyperalgesia 
(Cui et al., 2006). This study did not distinguish between effects of the centrally 
acting blocker on the central terminals of primary afferents and on TRPV1-
expressing dorsal horn neurons. Importantly, a recent study using an ultra-
sensitive genetically expressed TRPV1 reporter in mice failed to detect any 
TRPV1 expression in the spinal cord (Cavanaugh et al., 2011), and it has been 
pointed out that none of the claims for TRPV1-expressing neurons in the CNS 
(with the exception of a population of neurons in the supramammilary nucleus of 
the rostral midbrain) have identified or cloned TRPV1 transcripts in the CNS 
(Zhang et al., 2012). Thus, the analgesic effect I showed to be induced by 
intrathecal injection of TRPV1 antisense ODN may mainly come from its effect on 
primary sensory neurons, and include effects on presynaptic TRPV1 channels in 
nociceptor terminals in the dorsal horn. 
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TRPV1 channel agonists are used for pain therapy based on their ability to 
desensitize TRPV1 channel-containing neurons (Knotkova et al., 2008). However, 
the initial discomfort caused by agonist administration limits their use in clinical 
settings. Anti-hyperalgesic effects induced by antagonists of TRPV1 have also 
been observed in various rodent pain models (Gavva et al., 2005; Cui et al., 2006; 
Yu et al., 2008). In this regard, administration of AMG9810 (i.p.), a brain 
permeable antagonist that blocks all the major modes of TRPV1 activation (Gavva 
et al., 2005), dramatically attenuates mechanical allodynia and thermal 
hyperalgesia caused by Freund’s adjuvant injection (Gavva et al., 2005; Yu et al., 
2008). Knocking down the expression of TRPV1 channels is also sufficient to 
reverse behaviorally expressed hyperreflexia (mechanical and thermal) induced by 
nerve injury and inflammation (Christoph et al., 2006; Christoph et al., 2007; 
Christoph et al., 2008).  These findings indicate that TRPV1 channel is involved 
not only in the maintenance of thermal hyperalgesia as discussed above, but also 
mechanical allodynia. This is important because SCI produces both mechanical 
allodynia and thermal hyperalgesia. Indeed, I found that the TRPV1 antagonist 
AMG9810 reverses thermal and mechanical hyperalgesia following SCI. I further 
confirmed the contribution of enhanced TRPV1 channel function to SCI-induced 
chronic pain-related behavior by knocking down TRPV1 channels (in DRG and 
possibly spinal cord neurons) and showing that behaviorally expressed heat and 
mechanical hypersensitivity were both relieved.   
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  Figure 19. Potential general mechanisms involved in SCI-induced 
enhancement of TRPV1 function that promotes nociceptor SA and pain. The 
red color indicates the experiments performed in this study. The blue box 
indicates the intrinsic, transcriptionally-dependent alterations necessary for 
intrinsic SA (revealed after nociceptor dissociation). This intrinsic SA component 
together with ongoing activation of TRPV1 channels in the CNS and periphery 
in vivo may be necessary for chronic behavioral hypersensitivity and pain.  SO, 
subthreshold oscillations; SA, spontaneous activity; gK, K+ channel. 
conductance.  	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Although my studies show that TRPV1 function is persistently enhanced by 
SCI and is important for both nociceptor sensitization and behavioral 
hypersensitivity after SCI, recent findings have raised questions about the clinical 
utility of TRPV1 antagonists. Specifically, blockade of TRPV1 channels by 
commonly used TRPV1 blockers, including AMG9810, produces a significant and 
undesirable side effect of hyperthermia (Gavva et al., 2008; Othman et al., 2012). 
Fortunately, a group of TRPV1 blockers has now been discovered that lack this 
problematic side effect and these new drugs appear to offer considerable promise 
for targeting TRPV1 channels to treat chronic pain (Reilly et al., 2012). My results 
suggest that these drugs may be useful for treating the chronic, intractable pain 
that often follows SCI. 
 
7.4. Model for TRPV1 channels' contributions to chronic behavioral 
hypersensitivity and pain after SCI 
The results reported in this thesis support the following model for how TRPV1 
channels contribute to SCI-induced chronic pain (Fig. 19). As discussed above, it 
has been well established that glial cell activation and inflammatory factors play an 
important role in chronic pain following SCI. SCI-induced inflammation is not 
limited to the injury site; it spreads to both the brain, caudal spinal cord, and other 
organs (Zhao et al., 2007; Detloff et al., 2008; Carlton et al., 2009; Herrera et al., 
2010; Dulin et al., 2011; Dulin et al., 2013). Thus, inflammatory mediators may 
directly interact with primary sensory neuronal terminals in both the CNS and 
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periphery. In addition, inflammatory factors infiltrate into the dorsal root ganglia 
that contain the cell bodies of primary sensory neurons (McKay and McLachlan, 
2004). Similar to several inflammatory pain models (Ji et al., 2002; Breese et al., 
2005; Obata et al., 2005; Alessandri-Haber et al., 2008), SCI upregulates TRPV1 
in primary sensory neurons, as well as in superficial dorsal horn where nociceptor 
synaptic terminals are (Zhou et al., 2002). The endogenous agonists of TRPV1 are 
uncertain. However, it has been shown that various lipid products and other 
signals are able to sensitize or activate TRPV1 ion channels (Bang et al., 2010), 
including the endogenous cannabinoid receptor agonist anandamide, metabolites 
of arachidonic acid (AA), (Zygmunt et al., 1999; Hwang et al., 2000). It is unknown 
whether lipid products are elevated in DRG after SCI, but it has been 
demonstrated that SCI induces marked accumulation of AA and its 
cyclooxygenase and 5-lipooxygenase products, including prostaglandin E2 (PGE2) 
and leukotrienes B4 (LTB4), in the spinal cord (Liu and Xu, 2010; Dulin et al., 
2013). Moreover, both LTB4 and PGE2 have been shown to directly activate or 
sensitize TRPV1 channels (Lopshire and Nicol, 1998; Hwang et al., 2000; 
Moriyama et al., 2005). Together with TRPV1 upregulation, lipid signals 
accumulating in the spinal cord may increase the activity of TRPV1 channels in the 
central processes of DRG neurons, as well as TRPV1 channels in dorsal horn 
neurons, thus facilitating synaptic transmission and amplifying peripheral input to 
pain projection neurons in the dorsal horn. TRPV1 channels are Ca2+ and Na+ 
permeable (Tominaga, 2007). Thus, the activity of TRPV1 channels will result in 
direct depolarization of DRG neurons to increase SOs and elicit SA. It has been 
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reported that elevated activity of DRG neurons after injury promotes astrogliosis 
and microgliosis (Xie et al., 2009), which release cytokines, growth factors and 
other factors that enhance excitability of primary sensory neurons (Milligan and 
Watkins, 2009; Gao and Ji, 2010; Parpura and Zorec, 2010; Wang et al., 2012), 
This positive feedback loop potentially contributes to the initiation and 
maintenance of nociceptor hyperexcitability (Miller et al., 2009; Walters, 2012). 
Breaking the positive feedback loop by blocking TRPV1 might reduce intrinsic 
SA/hyperexcitability in DRG neurons after SCI. Interrupting this feedback loop to 
reduce intrinsic SA might require changes in nociceptor gene transcription (see 
below) and thus might be evident after knockdown of TRPV1 over several days in 
vivo (Fig. 7, 9B) but not after brief application of a TRPV1 antagonist in vitro (Fig. 
9C).  
 
The Ca2+ entering through TRPV1 channels is likely to play an important role in 
controlling gene expression in nociceptors.  In addition to enhancing TRPV1 
channel expression (Fig. 7), SCI elevates the function of TTX-sensitive Na+ 
channels and the expression of TTX-resistant Nav1.8 channels in DRG neurons 
(Yoshimura and de Groat, 1997; Yang et al., 2012). We also observed that SA in 
nociceptors is associated with chronic membrane depolarization and increased 
membrane resistance in the contusive SCI model (Bedi et al., 2010). This 
observation strongly suggests that intrinsic SA is also promoted by chronic closing 
or downregulation of K+ channels, which would not only increase membrane 
resistance but depolarize the cell soma. The membrane depolarization may 
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activate voltage-gated Ca2+ channels (and/or other Ca2+-sensitive proteins, see Fig. 
15) to increase the amplitude of SOs and enhance the generation of SA (Fig. 19). 
Thus, SCI produces multiple intrinsic alterations in nociceptors (perhaps 
representing a discrete hyperexcitable-SA state; Bedi et al., 2010; Walters, 2012) 
that probably depend upon altered gene expression and that can persist for at 
least a day after isolation of the nociceptors. 
 
An important question is why a TRPV1 channel blocker, AMG9810, rapidly 
reverses behavioral hypersensitivity after SCI when injected in vivo (Fig. 8), but 
the same blocker fails to reduce nociceptor SA when applied 1 day after 
dissociation (Fig. 11C). Part of the answer is that SA after SCI can occur in 
isolated noiceptors without the need for continuing activation of TRPV1 channels 
because of the intrinsic, transcriptionally-dependent alterations just described. 
However, while nociceptor SA also occurs in vivo (Carlton et al., 2009; Bedi et al., 
2010), and this SA may be necessary for chronic behavioral hypersensitivity and 
pain, either the nociceptor SA itself, or the degree of SA supported by the intrinsic 
alterations, may not be sufficient to drive the behavioral alterations, and thus 
additional TRPV1 actions may be required for behaviorally expressed effects in 
vivo. In our previous study, we demonstrated that SCI induces intrinsic SA in 
small DRG neurons that is correlated with hypersensitivity to various stimuli (Bedi 
et al., 2010).  However, it is not known whether this low frequency intrinsic SA 
alone is enough to induce and maintain SCI-induced pain behaviors. Our in vivo 
recording from teased dorsal root filaments indicates that both SA incidence and 
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frequency in primary sensory neurons are higher when the neurons are 
connected to the periphery than when the DRG and dorsal roots are 
disconnected from the periphery (Bedi et al., 2010). Thus, SA incidence and 
frequency in nociceptors connected to both the periphery and dorsal horn should 
be greater than that observed in vitro, and TRPV1 channels may enhance 
peripherally generated SA and evoked activity in vivo after SCI. These additional 
TRPV1 components may also play an important role in central sensitization and 
behavioral hypersensitivity. Yet another TRPV1 component of the pain pathway 
that would be blocked by AMG9810 in vivo but not in vitro are the TRPV1 
channels on the presynaptic terminals of nociceptors, which enhance 
transmission at the first synaptic relay of the pain pathway (Kim et al., 2009). In 
addition, AMG9810 would be expected to block any functionally important TRPV1 
channels on other pain-related neurons in the spinal cord and brain (Starowicz et 
al., 2008; Zhou et al., 2009; Kim et al., 2012). Future studies of these additional 
TRPV1 channel contributions to in vivo behavioral alterations should further 
define the roles of this important channel in SCI-induced chronic pain.  
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